细胞株Cell Lines 43-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV43
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID HO104
AC CVCL_E700
SY H0104
DR dbMHC; 48896
DR ECACC; 88052082
DR IHW; IHW9082
DR IMGT/HLA; 11633
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl82.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HO15.19
AC CVCL_0311
SY Ho15.19
DR MCCL; MCC:0000204
RX PubMed=9342182;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_T953 ! HET15
CA Spontaneously immortalized cell line
//
ID HO16.4C
AC CVCL_T952
SY HO16.4c
RX PubMed=9342182;
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_T954 ! HET16
CA Spontaneously immortalized cell line
//
ID HO275
AC CVCL_W086
DR Cosmic; 1522771
DR GEO; GSM726270
RX PubMed=21642991;
CC Omics: SNP array analysis.
CC Misspelling: 'NCI-H0275' in Cosmic 1522771.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HO301
AC CVCL_E701
SY H0301
DR dbMHC; 48876
DR ECACC; 88052055
DR IHW; IHW9055
DR IMGT/HLA; 10751
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl55.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HOB-02-C1
AC CVCL_F757
RX PubMed=8725178;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Conditionally immortalized cell line
//
ID HOB1
AC CVCL_J391
RX PubMed=2159767;
RX PubMed=7786033;
CC Doubling time: 22 hours (PubMed=2159767).
DI NCIt; C7873; Adult immunoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HOB1/ADR2.0
AC CVCL_J392
RX PubMed=1360209;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C7873; Adult immunoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_J391 ! HOB1
SX Male
CA Cancer cell line
//
ID HOB1/VCR0.1
AC CVCL_J393
RX PubMed=1360209;
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
DI NCIt; C7873; Adult immunoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_J391 ! HOB1
SX Male
CA Cancer cell line
//
ID HOB1/VCR0.5
AC CVCL_II74
RX PubMed=7786033;
RX PubMed=7903440;
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
DI NCIt; C7873; Adult immunoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_J391 ! HOB1
SX Male
CA Cancer cell line
//
ID HOB1/VCR1.0
AC CVCL_II75
RX PubMed=7786033;
CC Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).
DI NCIt; C7873; Adult immunoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_J391 ! HOB1
SX Male
CA Cancer cell line
//
ID HOBIT
AC CVCL_W632
SY Human OsteoBlast-like Initial Transfectant
RX PubMed=1373929;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HOC-1
AC CVCL_5454
SY HOC1
DR Cosmic; 877478
DR Cosmic; 1152558
RX PubMed=4016745;
RX PubMed=23415752;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Ascites.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5455 ! HOC-7
SX Female
CA Cancer cell line
//
ID HOC-21
AC CVCL_8692
DR ChEMBL-Cells; CHEMBL3308669
DR ChEMBL-Targets; CHEMBL614829
DR Cosmic; 877479
DR Cosmic; 1152559
RX PubMed=4436993;
RX PubMed=6163305;
RX PubMed=6174649;
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HOC-7
AC CVCL_5455
SY HOC7
DR Cosmic; 923105
RX PubMed=4016745;
RX PubMed=23415752;
RX PubMed=25230021;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: OCCP ovarian cancer cell line panel.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Ascites.
ST Source(s): PubMed=25230021
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9,11
ST D16S539: 9
ST D18S51: 14
ST D21S11: 30,31.2
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 8,9
ST D8S1179: 12,14
ST FGA: 23,25
ST Penta D: 13
ST Penta E: 7,12
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 14,16
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5454 ! HOC-1
SX Female
CA Cancer cell line
//
ID HOC-8
AC CVCL_5456
SY HOC8
RX PubMed=3756872;
RX PubMed=23415752;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Ascites.
ST Source(s): PubMed=11416159
ST Amelogenin: X
ST D18S51: 13,17
ST D21S11: 28,32.2
ST D8S1179: 10,12
ST FGA: 22
ST TH01: 6,9.3
ST vWA: 16,18
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HOC1119
AC CVCL_S689
SY HOC 1119
RX DOI=10.11277/stomatology1952.44.47;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HOC119
AC CVCL_8693
SY HOC-119; HOC 119; HOC 1-19
DR Cosmic; 1120709
RX DOI=10.11277/stomatology1952.44.47;
RX PubMed=10705089;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HOC1208
AC CVCL_8694
RX PubMed=10705089;
WW http://inhibitorlibraries.com/we-unearthed-that-the-development-of-oral-scc-cells-was-inhi
DI NCIt; C129857; Gingival squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HOC313
AC CVCL_8695
SY Hoc313; HOC-313
DR CGH-DB; 363-2
DR Cosmic; 930340
DR Cosmic; 1046030
DR Cosmic; 1123030
RX PubMed=2654810;
RX PubMed=12632084;
RX PubMed=17052259;
RX PubMed=17599052;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HOC512
AC CVCL_8696
SY HOC 512
RX DOI=10.11277/stomatology1952.44.47;
RX PubMed=10705089;
DI NCIt; C6064; Maxillary sinus squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HOC519
AC CVCL_8697
SY HOC 519
RX DOI=10.11277/stomatology1952.44.47;
RX PubMed=10705089;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HOC605
AC CVCL_8698
DR Cosmic; 1123033
RX PubMed=1624295;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HOC621
AC CVCL_8699
DR Cosmic; 1120710
RX PubMed=10705089;
WW http://inhibitorlibraries.com/we-unearthed-that-the-development-of-oral-scc-cells-was-inhi
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HOC719
AC CVCL_8700
DR Cosmic; 1123034
RX PubMed=11120485;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HOC719-NE
AC CVCL_8701
RX PubMed=11120485;
RX PubMed=12632084;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8700 ! HOC719
CA Cancer cell line
//
ID HOC719-PE
AC CVCL_8702
RX PubMed=11120485;
RX PubMed=12632084;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8700 ! HOC719
CA Cancer cell line
//
ID HOC815
AC CVCL_8703
SY Hoc815; HOC-815
DR CGH-DB; 357-2
DR Cosmic; 930341
DR Cosmic; 1046031
DR Cosmic; 1123031
RX PubMed=1624295;
RX PubMed=17052259;
RX PubMed=17599052;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HOC927
AC CVCL_8704
DR Cosmic; 1123035
RX PubMed=1624295;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HOCC
AC CVCL_M684
RX PubMed=15369135;
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HOCE
AC CVCL_4840
DR CLO; CLO_0050152
DR BioSample; SAMN03472148
DR RCB; RCB1514
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,9
ST D16S539: 11,13
ST D5S818: 10,11
ST D7S820: 10,12
ST TH01: 6,9
ST TPOX: 11
ST vWA: 14,18
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HOE6V
AC CVCL_4J71
RX Patent=US8835164;
CC Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00218.
CC Transfected with: UniProtKB; P03126; HPV16 E6 (variant form).
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1094 ! C-33 A
SX Female
CA Cancer cell line
//
ID HOEF
AC CVCL_4841
DR CLO; CLO_0050883
DR BioSample; SAMN03472199
DR RCB; RCB1010
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 10,11
ST D5S818: 10,12
ST D7S820: 10,12
ST TH01: 7
ST TPOX: 8,9
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HOFPAEC
AC CVCL_6G14
SY HPV16-transformed Ovine Fetal Pulmonary Artery Endothelial Cell line
RX PubMed=10409236;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Miscellaneous: As no precise cell line name was given in the paper, we assigned the name based on the transformation method, the species of origin and the primary cell type name.
OX NCBI_TaxID=9940; ! Ovis aries
CA Transformed cell line
//
ID HOG
AC CVCL_D354
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=1329795;
RX PubMed=14618099;
DI NCIt; C3288; Oligodendroglioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HOK-1
AC CVCL_B403
RX PubMed=1714884;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HOK-16A
AC CVCL_B404
SY HOK16A; Human Oral Keratinocytes-16A
RX PubMed=1330348;
RX PubMed=1654226;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B405 ! HOK-16B
SX Male
CA Transformed cell line
//
ID HOK-16A-BaP
AC CVCL_6G58
RX PubMed=1330348;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B404 ! HOK-16A
SX Male
CA Transformed cell line
//
ID HOK-16A-MSEE
AC CVCL_6G59
RX PubMed=1330348;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B404 ! HOK-16A
SX Male
CA Transformed cell line
//
ID HOK-16B
AC CVCL_B405
SY HOK16B; Human Oral Keratinocytes-16B
RX PubMed=1330348;
RX PubMed=1654226;
RX PubMed=10675494;
RX PubMed=12907203;
RX PubMed=21868764;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,12
ST D16S539: 12
ST D5S818: 9,10
ST D7S820: 12
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_B404 ! HOK-16A
SX Male
CA Transformed cell line
//
ID HOK-16B-BaP
AC CVCL_B406
RX PubMed=1330348;
RX PubMed=7784058;
RX PubMed=10675494;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B405 ! HOK-16B
SX Male
CA Transformed cell line
//
ID HOK-16B-BaP-T1
AC CVCL_B407
RX PubMed=7784058;
RX PubMed=10675494;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B406 ! HOK-16B-BaP
SX Male
CA Transformed cell line
//
ID HOK-16B-MSEE
AC CVCL_6G60
RX PubMed=1330348;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B405 ! HOK-16B
SX Male
CA Transformed cell line
//
ID HOKKAIDO
AC CVCL_E702
DR dbMHC; 48897
DR ECACC; 94082241
DR IHW; IHW9141
DR IMGT/HLA; 11684
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl141.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HOKN9
AC CVCL_X902
SY HOKN-9
RX PubMed=10761702;
RX PubMed=18704411;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HOKUG
AC CVCL_8705
DR CLO; CLO_0050937
DR BioSample; SAMN03472263
DR Cosmic; 877465
DR Cosmic; 1152545
DR RCB; RCB0657
RX PubMed=1698374;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 9
ST D5S818: 11
ST D7S820: 8,11
ST TH01: 6,9
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C40212; Cervical adenosquamous carcinoma, glassy cell variant
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HOM-1
AC CVCL_A611
SY HOM 1; HOM1
RX PubMed=158761;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID HOM-2
AC CVCL_A612
SY HOM 2; HOM2
DR BTO; BTO:0003106
DR dbMHC; 48898
DR ECACC; 98092902
DR IHW; IHW9005
DR IMGT/HLA; 10755
RX PubMed=158761;
RX PubMed=7614994;
WW http://bioinformatics.hsanmartino.it/ecbr/cl5.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HoMel-A1
AC CVCL_T050
RX PubMed=23982913;
CC Derived from metastatic site: Skin.
CC Breed/subspecies: Arabian.
OX NCBI_TaxID=9796; ! Equus caballus
SX Female
CA Cancer cell line
//
ID HoMel-L1
AC CVCL_T051
RX PubMed=23982913;
CC Breed/subspecies: Grey Lipizzaner.
OX NCBI_TaxID=9796; ! Equus caballus
SX Male
CA Cancer cell line
//
ID HOMM
AC CVCL_4842
SY Human Okuno Malignant Melanoma
DR CLO; CLO_0050928
DR BioSample; SAMN03472147
DR RCB; RCB1513
RX PubMed=9777403;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10,11
ST D16S539: 9
ST D5S818: 10,11
ST D7S820: 10
ST TH01: 9
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HONE-1
AC CVCL_8706
SY Hone-1; HONE1; Hone1
DR BioSample; SAMN03472391
DR ChEMBL-Cells; CHEMBL3308670
DR ChEMBL-Targets; CHEMBL614830
DR Cosmic; 755506
DR Cosmic; 944908
DR Cosmic; 1017620
DR Cosmic; 1300998
DR Cosmic; 1322948
DR Cosmic; 2366881
DR GEO; GSM375844
DR GEO; GSM378801
DR GEO; GSM378802
DR TOKU-E; 3587
RX PubMed=2556716;
RX PubMed=24991015;
CC Problematic cell line: Seems to bear part of the HeLa genomic sequence; may be a derivative of HeLa and another cell of unknown origin (PubMed=24991015).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Deep RNAseq analysis.
CC Misspelling: Occasionally 'HOME-1'.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 10,12
ST D16S539: 9,10,11
ST D18S51: 13,16
ST D21S11: 27,30
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 12
ST FGA: 18,21
ST Penta D: 9,12
ST Penta E: 17,20
ST TH01: 6,9
ST TPOX: 8,12
ST vWA: 14,16
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HONE-1/CPT30
AC CVCL_M595
SY CPT30
DR ChEMBL-Cells; CHEMBL3307934
DR ChEMBL-Targets; CHEMBL614470
RX PubMed=12097280;
CC Selected for resistance to: ChEBI; CHEBI:27656; Camptothecin (CPT).
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8706 ! HONE-1
SX Male
CA Cancer cell line
//
ID HONE-1/CPT30R
AC CVCL_M596
SY CPT30R
RX PubMed=12097280;
CC Selected for resistance to: ChEBI; CHEBI:27656; Camptothecin (CPT).
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M595 ! HONE-1/CPT30
SX Male
CA Cancer cell line
//
ID HOON
AC CVCL_IN52
RX PubMed=3262645;
RX PubMed=6230491;
CC Doubling time: 24 hours (PubMed=3262645).
DI NCIt; C3168; Childhood acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HOP-1
AC CVCL_J127
DR ATCC; CRL-11881
RX Patent=US5830651;
CC Discontinued: ATCC; CRL-11881; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID HOP-18
AC CVCL_H642
SY HOP 18; HOP18; Hop18
DR BioSample; SAMN03472883
DR ChEMBL-Cells; CHEMBL3307783
DR ChEMBL-Targets; CHEMBL614809
DR GEO; GSM206506
RX PubMed=2536293;
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 12
ST D18S51: 15
ST D21S11: 29
ST D3S1358: 18,19
ST D5S818: 9,11
ST D7S820: 9,11
ST D8S1179: 11,12
ST FGA: 23,25
ST Penta D: 13
ST Penta E: 13
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 19
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HOP-19
AC CVCL_H643
DR ChEMBL-Cells; CHEMBL3308671
DR ChEMBL-Targets; CHEMBL614832
RX PubMed=2536293;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HOP-62
AC CVCL_1285
SY HOP 62; HOP62; Hop62
DR BTO; BTO:0004080
DR EFO; EFO_0006439
DR BioSample; SAMN03471402
DR ChEMBL-Cells; CHEMBL3307671
DR ChEMBL-Targets; CHEMBL614643
DR Cosmic; 875855
DR Cosmic; 905972
DR Cosmic; 974289
DR Cosmic; 1092603
DR Cosmic; 1146945
DR Cosmic; 1175861
DR Cosmic; 1305344
DR Cosmic; 1995442
DR Cosmic; 1998445
DR Cosmic-CLP; 905972
DR GDSC; 905972
DR GEO; GSM50211
DR GEO; GSM50274
DR GEO; GSM206507
DR GEO; GSM434275
DR GEO; GSM750804
DR GEO; GSM794404
DR GEO; GSM799338
DR GEO; GSM799401
DR GEO; GSM846357
DR GEO; GSM1153408
DR GEO; GSM1181256
DR GEO; GSM1181314
DR GEO; GSM1374542
DR IGRhCellID; HOP-62_02GEO
DR SKY/M-FISH/CGH; 2896
RX DOI=10.4172/2157-7145.S2-005;
RX PubMed=2041050;
RX PubMed=2536293;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=13
WW http://tcpaportal.org/mclp/
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 39 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 11,12
ST D18S51: 14
ST D19S433: 13,14
ST D21S11: 30
ST D2S1338: 19
ST D3S1358: 14,18
ST D5S818: 11
ST D7S820: 10,12
ST D8S1179: 13
ST FGA: 22,24
ST Penta D: 9,13
ST Penta E: 10,19
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HOP-92
AC CVCL_1286
SY HOP 92; HOP92; Hop92
DR BTO; BTO:0004085
DR EFO; EFO_0006440
DR BioSample; SAMN03471631
DR ChEMBL-Cells; CHEMBL3308091
DR ChEMBL-Targets; CHEMBL613889
DR Cosmic; 687783
DR Cosmic; 875856
DR Cosmic; 897510
DR Cosmic; 905973
DR Cosmic; 974290
DR Cosmic; 1044247
DR Cosmic; 1092604
DR Cosmic; 1146946
DR Cosmic; 1175862
DR Cosmic; 1305345
DR Cosmic; 1312330
DR Cosmic; 1995443
DR Cosmic; 1998446
DR Cosmic-CLP; 905973
DR GDSC; 905973
DR GEO; GSM50212
DR GEO; GSM50275
DR GEO; GSM206508
DR GEO; GSM434299
DR GEO; GSM750805
DR GEO; GSM794405
DR GEO; GSM799339
DR GEO; GSM799402
DR GEO; GSM846358
DR GEO; GSM1153409
DR GEO; GSM1153410
DR GEO; GSM1181257
DR GEO; GSM1181315
DR GEO; GSM1669890
DR IGRhCellID; HOP-92_02GEO
DR SKY/M-FISH/CGH; 2810
RX PubMed=2041050;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=14
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 79.5 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=19372543; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 12
ST D18S51: 12,18
ST D19S433: 13
ST D21S11: 30
ST D2S1338: 19,23
ST D3S1358: 18
ST D5S818: 12
ST D7S820: 8,10
ST D8S1179: 14 (PubMed=19372543)
ST D8S1179: 9,14 (PubMed=25877200)
ST FGA: 19,21
ST Penta D: 10
ST Penta E: 12
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 15
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HOPC 1F/12
AC CVCL_3515
SY HOPC-1F/12
DR CLO; CLO_0003793
DR ATCC; TIB-13
CC Breed/subspecies: BALB/c.
DI NCIt; C21631; Mouse plasmacytoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID HOR
AC CVCL_E703
DR dbMHC; 48899
DR ECACC; 88052053
DR IHW; IHW9053
DR IMGT/HLA; 10757
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl53.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Horse
AC CVCL_9124
DR CLO; CLO_0003794
DR ATCC; CRL-6583
WW http://www.grsykes.com/pdf/dna_species_id_notes.pdf
CC Problematic cell line: Misidentified. Originally thought to be of horse origin but found to be from hamster (see WWW link).
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Miscellaneous: Even if it was not a misidentified cell line, it would probably win the award of the dummest name for a cell line! (hope the originator of this cell line never reads this comment).
OX NCBI_TaxID=10029; ! Cricetulus griseus
SX Sex undetermined
CA Undefined cell line type
//
ID HOS
AC CVCL_0312
DR BTO; BTO:0003904
DR CLO; CLO_0003795
DR CLO; CLO_0050810
DR EFO; EFO_0002196
DR MCCL; MCC:0000205
DR CLDB; cl1702
DR CLDB; cl1706
DR CLDB; cl7155
DR ATCC; CRL-1543
DR BCRC; 60308
DR BCRJ; 0339
DR BioSample; SAMN01821560
DR BioSample; SAMN01821729
DR BioSample; SAMN03471393
DR CCLE; HOS_BONE
DR CCRID; 3111C0001CCC000038
DR ChEMBL-Cells; CHEMBL3308811
DR ChEMBL-Targets; CHEMBL614736
DR Cosmic; 687928
DR Cosmic; 759899
DR Cosmic; 907060
DR Cosmic; 931037
DR Cosmic; 931910
DR Cosmic; 1044082
DR Cosmic; 1070840
DR Cosmic; 1074391
DR Cosmic; 1176621
DR Cosmic; 1529902
DR Cosmic-CLP; 907060
DR ECACC; 87070202
DR GDSC; 907060
DR GEO; GSM170248
DR GEO; GSM185087
DR GEO; GSM185088
DR GEO; GSM320827
DR GEO; GSM827319
DR GEO; GSM879208
DR GEO; GSM887088
DR GEO; GSM888159
DR GEO; GSM1669891
DR GEO; GSM1676300
DR GEO; GSM1701635
DR ICLC; HTL04003
DR IFO; IFO50106
DR IGRhCellID; HOS
DR IZSLER; BS TCL 69
DR RCB; RCB0992
RX PubMed=2823272;
RX PubMed=12645653;
RX PubMed=15150091;
RX PubMed=19787792;
RX PubMed=21519327;
RX PubMed=22460905;
RX PubMed=26351324;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-420.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; ECACC; JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 10,13
ST D5S818: 13
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HOS [Dog osteosarcoma]
AC CVCL_L356
RX PubMed=9673952;
CC Doubling time: 42.0 +- 0.1 hours (PubMed=9673952).
CC Breed/subspecies: Mixed breed.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID HOS-CCR5
AC CVCL_1H19
SY HOS.CCR5
DR NIH-ARP; 3519-30
CC Transfected with: HGNC; 1606; CCR5.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1H17 ! HOS-pBABE-puro
SX Female
CA Cancer cell line
//
ID HOS-CD4
AC CVCL_W650
SY HOS.CD4
DR NIH-ARP; 3313-13
CC Transfected with: HGNC; 1678; CD4.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0312 ! HOS
SX Female
CA Cancer cell line
//
ID HOS-CD4-CCR1
AC CVCL_1D94
SY HOS-CD4-CCR-1; HOS-CD4.CCR-1; HOS.CD4.CCR1; HOS.CD4.CKR-1
DR NIH-ARP; 3314-198
RX PubMed=8649511;
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: HGNC; 1602; CCR1.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W650 ! HOS-CD4
SX Female
CA Cancer cell line
//
ID HOS-CD4-CCR2b
AC CVCL_1D95
SY HOS-CD4-CCR-2B; HOS-CD4.CCR-2B; HOS.CD4.CCR2b
DR NIH-ARP; 3315-229
RX PubMed=8649511;
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: HGNC; 1603; CCR2.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W650 ! HOS-CD4
SX Female
CA Cancer cell line
//
ID HOS-CD4-CCR3
AC CVCL_1D96
SY HOS.CD4.CCR3; HOS.CD4.CKR-3
DR NIH-ARP; 3316-230
RX PubMed=8649511;
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: HGNC; 1604; CCR3.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W650 ! HOS-CD4
SX Female
CA Cancer cell line
//
ID HOS-CD4-CCR4
AC CVCL_1D97
SY HOS.CD4.CCR4
DR NIH-ARP; 3317-231
RX PubMed=8649511;
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: HGNC; 1605; CCR4.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W650 ! HOS-CD4
SX Female
CA Cancer cell line
//
ID HOS-CD4-CCR5
AC CVCL_1D98
SY HOS-CD4.CCR5; HOS.CD4.CCR5; HOS.CD4-CKR5
DR NIH-ARP; 3318-326
RX PubMed=8649511;
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: HGNC; 1606; CCR5.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W650 ! HOS-CD4
SX Female
CA Cancer cell line
//
ID HOS-CD4-Fusin
AC CVCL_1D99
SY HOS-CD4.Fusin
DR NIH-ARP; 3319-368
RX PubMed=8649511;
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: HGNC; 2561; CXCR4.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W650 ! HOS-CD4
SX Female
CA Cancer cell line
//
ID HOS-CD4-pBABE-puro
AC CVCL_1E00
SY HOS-CD4.pBABE-puro; HOS.CD4.pBABE-puro
DR NIH-ARP; 3320-14
RX PubMed=8649511;
CC Transfected with: HGNC; 1678; CD4.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W650 ! HOS-CD4
SX Female
CA Cancer cell line
//
ID HOS-CXCR4
AC CVCL_1H18
SY HOS.CXCR4
DR NIH-ARP; 3518-313
CC Transfected with: HGNC; 2561; CXCR4.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1H17 ! HOS-pBABE-puro
SX Female
CA Cancer cell line
//
ID HOS-pBABE-puro
AC CVCL_1H17
SY HOS.p.BABE-puro
DR NIH-ARP; 3517-36
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0312 ! HOS
SX Female
CA Cancer cell line
//
ID HOSC1
AC CVCL_IW50
RX PubMed=25193510;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HOSE 11-12
AC CVCL_7671
SY HOSE11-12
DR BTO; BTO:0004435
RX PubMed=15489894;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HOSE 17-1
AC CVCL_7672
SY HOSE17-1
DR BTO; BTO:0004437
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HOSE 6-3
AC CVCL_7673
SY HOSE6-3
DR BTO; BTO:0004436
RX PubMed=7796885;
RX PubMed=15489894;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HOSE1-E7/hTERT
AC CVCL_E232
RX PubMed=15956975;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HOSONUMA
AC CVCL_E704
SY HOSONUM
DR dbMHC; 48900
DR ECACC; 94082229
DR IHW; IHW9130
DR IMGT/HLA; 11673
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl130.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Misspelling: Occasionally 'HONOSUMA'.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HOTC-3
AC CVCL_8707
SY HOTC 3; HOTC3; Human Ovarian Teratocarcinoma Cell line-3
RX CelloPub=CLPUB00050;
RX PubMed=6174649;
DI NCIt; C8110; Ovarian teratoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HOTHC
AC CVCL_8708
DR CLO; CLO_0050950
DR BioSample; SAMN03472267
DR RCB; RCB0662
RX PubMed=10457904;
RX PubMed=17022149;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8
ST D16S539: 12
ST D5S818: 12
ST D7S820: 8
ST TH01: 6
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HOTHC-SF
AC CVCL_8709
DR CLO; CLO_0050947
DR RCB; RCB0690
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8
ST D16S539: 12
ST D5S818: 12
ST D7S820: 8
ST TH01: 6
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8708 ! HOTHC
SX Female
CA Cancer cell line
//
ID HOUA-I
AC CVCL_3867
SY HOUA-1; HOUA
DR CLO; CLO_0050886
DR BioSample; SAMN03472265
DR Cosmic; 713498
DR Cosmic; 1241348
DR Cosmic; 1622897
DR RCB; RCB0659
RX CelloPub=CLPUB00051;
CC Doubling time: ~50 hours (CelloPub=CLPUB00051).
CC Misspelling: 'HOOUA' in Cosmic 1241348.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 14,15
ST D13S317: 13,14,15
ST D16S539: 9,13,14
ST D5S818: 12,14,15
ST D7S820: 10,11,12
ST TH01: 6,9
ST TPOX: 8,9
ST vWA: 18,19,20
DI NCIt; C7558; Endometrial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_A778 ! HOUA-II
SX Female
CA Cancer cell line
//
ID HOUA-II
AC CVCL_A778
RX CelloPub=CLPUB00051;
CC Doubling time: 60 hours (CelloPub=CLPUB00051).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3867 ! HOUA-I
SX Female
CA Transformed cell line
//
ID HOUFXXX
AC CVCL_E957
DR CLO; CLO_0051368
DR BioSample; SAMN03472166
DR RCB; RCB1171
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 10,11
ST D5S818: 10,12
ST D7S820: 10
ST TH01: 7
ST TPOX: 8,9
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID HOV
AC CVCL_0B90
DR Cosmic; 2239133
RX PubMed=9559344;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HOVTAX2
AC CVCL_AV53
RX PubMed=22115851;
WW http://technologies.ventures.mayoclinic.org/technologies/2010-305_new-cell-lines
ST Source(s): PubMed=22115851
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 11,12
ST D16S539: 13
ST D18S51: 13,14
ST D21S11: 30,31
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 10,13
ST FGA: 22,23
ST TPOX: 11
ST vWA: 14,16
DI NCIt; C4182; Serous surface papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HOVTAX2-paclitaxel resistant
AC CVCL_AV60
RX PubMed=22115851;
WW http://technologies.ventures.mayoclinic.org/technologies/2010-305_new-cell-lines
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
DI NCIt; C4182; Serous surface papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AV53 ! HOVTAX2
SX Female
CA Cancer cell line
//
ID HP
AC CVCL_3715
SY HT1080 poly
DR CLO; CLO_0003797
DR ATCC; CRL-12012
RX Patent=US5591624;
CC Group: Retrovirus packaging cell line.
CC Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,12
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 6
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0317 ! HT-1080
SX Male
CA Cancer cell line
//
ID HP-1
AC CVCL_C309
DR Cosmic; 1032369
RX PubMed=7695406;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HP-2
AC CVCL_C310
DR Cosmic; 1032392
RX PubMed=7695406;
DI NCIt; C7985; Epithelioid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HP-3
AC CVCL_C311
DR Cosmic; 1032377
RX PubMed=7695406;
DI NCIt; C7985; Epithelioid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HP-A1
AC CVCL_6G10
RX PubMed=1318503;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA209].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6G11 ! HP-A2
OI CVCL_6G12 ! HP-W
SX Female
CA Transformed cell line
//
ID HP-A2
AC CVCL_6G11
RX PubMed=1318503;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA209].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6G10 ! HP-A1
OI CVCL_6G12 ! HP-W
SX Female
CA Transformed cell line
//
ID Hp-E-1
AC CVCL_HF43
RX PubMed=27083164;
CC Group: Insect cell line.
CC Doubling time: 136.7 hours (PubMed=27083164).
OX NCBI_TaxID=93412; ! Holotrichia parallela
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID HP-W
AC CVCL_6G12
RX PubMed=1318503;
CC Transformant: Ad-SV40.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6G10 ! HP-A1
OI CVCL_6G11 ! HP-A2
SX Female
CA Transformed cell line
//
ID HP100-1
AC CVCL_8710
SY HL60 HP100-1
DR CLO; CLO_0050987
DR RCB; RCB0769
RX PubMed=2796382;
RX PubMed=9290701;
CC Selected for resistance to: ChEBI; CHEBI:16240; Hydrogen peroxide.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 8
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HP50-2
AC CVCL_8711
SY HL60 HP50-2
DR CLO; CLO_0050977
DR RCB; RCB0768
RX PubMed=2796382;
RX PubMed=9290701;
CC Selected for resistance to: ChEBI; CHEBI:16240; Hydrogen peroxide.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 8
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID HP6000
AC CVCL_C481
DR CLO; CLO_0003798
DR ATCC; CRL-1754
RX PubMed=6209201;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID HP6001
AC CVCL_C482
DR CLO; CLO_0003799
DR ATCC; CRL-1755
RX PubMed=6209201;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID HP6002
AC CVCL_C483
DR CLO; CLO_0003800
DR ATCC; CRL-1788
RX PubMed=6209201;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID HP6003
AC CVCL_C484
DR CLO; CLO_0003801
DR ATCC; CRL-1756
RX PubMed=6209201;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID HP6014
AC CVCL_C485
DR CLO; CLO_0003802
DR ATCC; CRL-1752
RX PubMed=6209201;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID HP6016
AC CVCL_C486
DR CLO; CLO_0003803
DR ATCC; CRL-1787
RX PubMed=6209201;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID HP6017
AC CVCL_C487
DR CLO; CLO_0003804
DR ATCC; CRL-1753
RX PubMed=6209201;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID HP6020
AC CVCL_C488
DR CLO; CLO_0003805
DR ATCC; CRL-1789
RX PubMed=6209201;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID HP6023
AC CVCL_C489
DR CLO; CLO_0003806
DR ATCC; CRL-1776
RX PubMed=6209201;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID HP6025
AC CVCL_C490
DR CLO; CLO_0003807
DR ATCC; CRL-1775
RX PubMed=6209201;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID HP6045
AC CVCL_C491
DR CLO; CLO_0003808
DR ATCC; CRL-1757
RX PubMed=6209201;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID HP6047
AC CVCL_C492
DR CLO; CLO_0003809
DR ATCC; CRL-1774
RX PubMed=6209201;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID HP6050
AC CVCL_C493
DR CLO; CLO_0003810
DR ATCC; CRL-1768
RX PubMed=6209201;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID HP6053
AC CVCL_C494
SY HP 6053
DR CLO; CLO_0003811
DR ATCC; CRL-1758
DR ECACC; 94050510
RX PubMed=6209201;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID HP6054
AC CVCL_C495
SY HP 6054
DR CLO; CLO_0003812
DR ATCC; CRL-1763
DR ECACC; 93092704
RX PubMed=6209201;
CC Discontinued: ECACC; 93092704; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID HP6058
AC CVCL_C496
DR CLO; CLO_0003813
DR ATCC; CRL-1786
RX PubMed=6209201;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID HP75
AC CVCL_3516
SY HP-75
DR ATCC; CRL-2506
DR BioSample; SAMN03471601
RX DOI=10.1007/BF02782609;
RX PubMed=15541569;
CC Transformant: Ad5-SV40 (AD-SVR4).
CC Discontinued: ATCC; CRL-2506; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 8,12
ST D13S317: 10,11
ST D16S539: 11,12
ST D5S818: 10,11
ST D7S820: 7,8
ST TH01: 8
ST TPOX: 10,11
ST vWA: 17,18
DI NCIt; C3329; Pituitary gland adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HPA
AC CVCL_W418
RX PubMed=6243244;
DI NCIt; C6242; Oral cavity pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HPa 33
AC CVCL_Z875
SY HPa-33; H Pa 33
RX DOI=10.1016/0022-1910(75)90074-8;
RX PubMed=4810369;
CC Group: Insect cell line.
OX NCBI_TaxID=6978; ! Periplaneta americana
SX Male
CA Spontaneously immortalized cell line
//
ID HPa 34
AC CVCL_Z876
SY HPa-34
RX DOI=10.1016/0022-1910(75)90074-8;
CC Group: Insect cell line.
OX NCBI_TaxID=6978; ! Periplaneta americana
SX Female
CA Spontaneously immortalized cell line
//
ID HPAC
AC CVCL_3517
SY Hpac
DR BTO; BTO:0004121
DR CLO; CLO_0003814
DR EFO; EFO_0002197
DR ATCC; CRL-2119
DR BCRC; 60495
DR BioSample; SAMN03472247
DR CCLE; HPAC_PANCREAS
DR CCRID; 3111C0001CCC000189
DR ChEMBL-Cells; CHEMBL3308388
DR ChEMBL-Targets; CHEMBL612595
DR Cosmic; 913306
DR Cosmic; 1571784
DR Cosmic; 1995444
DR Cosmic; 2434094
DR Cosmic-CLP; 1298136
DR GDSC; 1298136
DR GEO; GSM621897
DR GEO; GSM206509
DR GEO; GSM784701
DR GEO; GSM887089
DR GEO; GSM888160
DR GEO; GSM1024401
DR GEO; GSM1374545
DR GEO; GSM1669892
DR IGRhCellID; HPAC
DR PRIDE; PXD003198
RX DOI=10.4172/jpb.1000057;
RX PubMed=20418756;
RX PubMed=22460905;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=25939163;
RX PubMed=25984343;
RX PubMed=27259358;
RX PubMed=27397505;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=HPAC
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 23 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Proteome analysis by 2D-DE/MS.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 11
ST D16S539: 9,10
ST D18S51: 16
ST D21S11: 30
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 10,12
ST D8S1179: 12,14
ST FGA: 24
ST Penta D: 13
ST Penta E: 15,17
ST TH01: 9.3
ST TPOX: 10,11
ST vWA: 15,17
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HPaC-79
AC CVCL_M121
SY HPaC 79; HPaC79
RX PubMed=3138611;
RX PubMed=6837290;
DI NCIt; C5942; Parotid gland squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HPAE-26
AC CVCL_3716
SY WC00107
DR CLO; CLO_0003815
DR ATCC; CRL-2598
DR BioSample; SAMN03471687
DR Coriell; WC00107
CC Part of: Wistar Institute Special Collection vascular cell lines.
CC Discontinued: ATCC; CRL-2598; true.
CC Discontinued: Coriell; WC00107; probable.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 13,14
ST D5S818: 12
ST D7S820: 10
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0E12 ! HAAE-26
OI CVCL_3292 ! HIVE-26
OI CVCL_3718 ! HPVE-26
SX Male
CA Finite cell line
//
ID HPAF
AC CVCL_B284
SY HPAF-I
DR Cosmic; 724640
DR Cosmic; 736274
DR Cosmic; 808174
DR Cosmic; 872999
DR Cosmic; 922245
DR Cosmic; 933527
DR Cosmic; 948376
DR Cosmic; 948735
RX PubMed=7034925;
RX PubMed=11169957;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HPAF-II
AC CVCL_0313
SY HPAFII; HPAF-2; HPAF2; HPAF/CD18; CD18/HPAF; HPAF-II/CD18; CD-18; CD18; CD 18
DR BTO; BTO:0003266
DR CLO; CLO_0003816
DR EFO; EFO_0002198
DR GEO; GSM1374546
DR GEO; GSM1374547
DR MCCL; MCC:0000206
DR ATCC; CRL-1997
DR BioSample; SAMN03471950
DR CCLE; HPAFII_PANCREAS
DR CGH-DB; 165-1
DR CGH-DB; 9274-4
DR ChEMBL-Cells; CHEMBL3308744
DR ChEMBL-Targets; CHEMBL1075467
DR Cosmic; 710858
DR Cosmic; 724869
DR Cosmic; 868241
DR Cosmic; 913304
DR Cosmic; 922247
DR Cosmic; 1108343
DR Cosmic; 1299299
DR Cosmic; 1320467
DR Cosmic; 1571777
DR Cosmic; 2046534
DR Cosmic; 2434099
DR Cosmic-CLP; 724869
DR GDSC; 724869
DR GEO; GSM206510
DR GEO; GSM385517
DR GEO; GSM385528
DR GEO; GSM621899
DR GEO; GSM784696
DR GEO; GSM827289
DR GEO; GSM887090
DR GEO; GSM888161
DR GEO; GSM1024402
DR GEO; GSM1669893
DR IGRhCellID; HPAFII
DR IZSLER; BS TCL 170
DR PRIDE; PXD003198
DR TOKU-E; 4028
RX DOI=10.4172/jpb.1000057;
RX PubMed=2734279;
RX PubMed=11787853;
RX PubMed=12692724;
RX PubMed=15126341;
RX PubMed=15367897;
RX PubMed=18380791;
RX PubMed=20418756;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27259358;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=HPAF-II
WW http://www.addexbio.com/productdetail?pid=4678
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 70 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Proteome analysis by 2D-DE/MS.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Caution: Could not find proof that the CD18 subline of HPAF is really HPAF-II but many indirect evidences points in this direction. If someone read this comment and can help us, please do.
CC Misspelling: 'HPAF11' in PubMed=25984343.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 11,13
ST D18S51: 13
ST D21S11: 30,31
ST D3S1358: 14,18
ST D5S818: 11,13
ST D7S820: 10,13
ST D8S1179: 11,12
ST FGA: 21,24
ST Penta D: 9,13
ST Penta E: 10,13
ST TH01: 9
ST TPOX: 8
ST vWA: 17
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B284 ! HPAF
SX Male
CA Cancer cell line
//
ID HPAF/CD11
AC CVCL_B285
SY HPAF-CD11; CD11/HPAF; CD11; CD-11; CD 11
DR Cosmic; 922246
RX PubMed=2734279;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B284 ! HPAF
SX Male
CA Cancer cell line
//
ID HPAF1
AC CVCL_1Y72
DR ATCC; CRL-11707
RX Patent=US5462870;
RX PubMed=7713331;
CC Discontinued: ATCC; CRL-11707; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Spontaneously immortalized cell line
//
ID HPAM1
AC CVCL_1Y73
DR EFO; EFO_0006280
DR ATCC; CRL-11706
RX Patent=US5462870;
RX PubMed=7713331;
CC Discontinued: ATCC; CRL-11706; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Spontaneously immortalized cell line
//
ID HPB-ALL
AC CVCL_1820
SY HPB/ALL; HPBALL; FCCH1018
DR BTO; BTO:0001952
DR CLO; CLO_0003817
DR CLO; CLO_0050988
DR BioSample; SAMN01821632
DR BioSample; SAMN03473562
DR CCLE; HPBALL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 801726
DR Cosmic; 913406
DR Cosmic; 919159
DR Cosmic; 933550
DR Cosmic; 998736
DR Cosmic; 999754
DR Cosmic; 1037689
DR Cosmic; 1115583
DR Cosmic; 1130235
DR Cosmic; 1151779
DR Cosmic; 1224373
DR Cosmic; 1281368
DR Cosmic; 1330499
DR Cosmic; 1524796
DR Cosmic; 1641378
DR Cosmic; 1664521
DR Cosmic; 1760522
DR Cosmic; 2165711
DR DSMZ; ACC-483
DR GEO; GSM887091
DR GEO; GSM888162
DR NCBI_Iran; C213
DR RCB; RCB1935
DR TKG; TKG 0199
RX PubMed=203546;
RX PubMed=1373528;
RX PubMed=6582512;
RX PubMed=9738977;
RX PubMed=9933131;
RX PubMed=22460905;
RX PubMed=22675565;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-55.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~50 hours (DSMZ).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,10
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 11
ST TH01: 7,9
ST TPOX: 8,12
ST vWA: 18,20
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HPB-MLT
AC CVCL_7959
SY FCCH1019
DR BioSample; SAMN03151780
DR Cosmic; 721703
DR Cosmic; 801733
DR Cosmic; 998731
DR TKG; TKG 0361
RX PubMed=203546;
RX PubMed=1373528;
RX PubMed=10071127;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HPB-ALL derivative (PubMed=12592342, PubMed=20143388).
CC Misspelling: 'MPB-MLT' in PubMed=10071127.
ST Source(s): TKG
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 8,10
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 11
ST TH01: 7,9
ST TPOX: 8,12
ST vWA: 18,20
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1820 ! HPB-ALL
SX Male
CA Cancer cell line
//
ID HPB-Null
AC CVCL_7960
SY HPB-NULL; HPB-null; HPB/Null; HPB Null; HPB null
DR Cosmic; 998711
DR Cosmic; 999750
DR Cosmic; 1037727
DR Cosmic; 2491080
RX PubMed=9067587;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HPC-1
AC CVCL_6C64
RX CelloPub=CLPUB00297;
CC Doubling time: 26 hours (CelloPub=CLPUB00297).
CC Derived from metastatic site: Ascites.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID HPC-1H5
AC CVCL_6C65
RX PubMed=12198767;
CC Derived from metastatic site: Ascites.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6C64 ! HPC-1
SX Female
CA Cancer cell line
//
ID HPC-1P5
AC CVCL_6C66
RX PubMed=12198767;
CC Derived from metastatic site: Ascites.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6C64 ! HPC-1
SX Female
CA Cancer cell line
//
ID HPC-3
AC CVCL_6C67
RX CelloPub=CLPUB00298;
CC Doubling time: ~21 hours (CelloPub=CLPUB00298).
CC Derived from metastatic site: Ascites.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HPC-36
AC CVCL_M169
RX PubMed=571046;
RX PubMed=6244232;
RX PubMed=15643172;
CC Miscellaneous: Cell line has been lost (PubMed=15643172).
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HPC-36M
AC CVCL_8446
SY HPC36M
DR BioSample; SAMN03151711
RX PubMed=10754530;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to originate from a prostate carcinoma.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Caution: Was reported to derive from HPC-36 (CVCL_M169).
ST Source(s): PubMed=11416159
ST Amelogenin: X
ST D18S51: 16
ST D21S11: 27,28
ST D8S1179: 12,13
ST FGA: 18,21
ST TH01: 7
ST vWA: 16,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID HPC-3H4
AC CVCL_6C68
RX PubMed=10385366;
CC Derived from metastatic site: Ascites.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6C67 ! HPC-3
SX Male
CA Cancer cell line
//
ID HPC-3P4a
AC CVCL_6C69
RX PubMed=11345134;
CC Derived from metastatic site: Ascites.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6C67 ! HPC-3
SX Male
CA Cancer cell line
//
ID HPC-4
AC CVCL_6C70
RX CelloPub=CLPUB00298;
CC Doubling time: ~24 hours (CelloPub=CLPUB00298).
CC Derived from metastatic site: Ascites.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID HPC-4H4
AC CVCL_6C71
RX PubMed=11893931;
CC Derived from metastatic site: Ascites.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6C70 ! HPC-4
SX Male
CA Cancer cell line
//
ID HPC-4P4a
AC CVCL_6C72
RX PubMed=11893931;
CC Derived from metastatic site: Ascites.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6C70 ! HPC-4
SX Male
CA Cancer cell line
//
ID HPC-Y0
AC CVCL_6912
AS CVCL_A067
SY HPC-YO; HPCY0
DR Cosmic; 730529
RX PubMed=2208167;
DI NCIt; C7977; Pancreatic acinar cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HPC-Y1
AC CVCL_6913
DR Cosmic; 730518
RX PubMed=2208167;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HPC-Y11
AC CVCL_6914
DR Cosmic; 730521
RX PubMed=2208167;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HPC-Y15
AC CVCL_6915
RX PubMed=2208167;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HPC-Y19
AC CVCL_6916
DR Cosmic; 730522
RX PubMed=2208167;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HPC-Y21
AC CVCL_A069
DR Cosmic; 730524
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HPC-Y23
AC CVCL_A068
DR Cosmic; 730525
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HPC-Y25
AC CVCL_6917
DR Cosmic; 730526
RX PubMed=2208167;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HPC-Y3
AC CVCL_A066
DR Cosmic; 730519
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HPC-Y5
AC CVCL_6918
DR CCRID; 3142C0001000000502
DR Cosmic; 730520
RX PubMed=2208167;
CC Derived from metastatic site: Lymph node.
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HPC-Y9
AC CVCL_6919
RX PubMed=2208167;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HPC-YP
AC CVCL_6920
RX PubMed=2208167;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HPC-YS
AC CVCL_6921
RX PubMed=2208167;
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HPC-YT
AC CVCL_A070
DR Cosmic; 730530
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HPC0A07
AC CVCL_9T02
SY HPCOA07
RX Patent=US7666672;
RX PubMed=18635871;
CC From: ReNeuron, Ltd.
CC Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 04092302.
CC Transfected with: HGNC; 7553; MYC.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Conditionally immortalized cell line
//
ID HPCT-03-ts
AC CVCL_9W32
SY Human Proximal Convoluted Tubule-03-ts
RX PubMed=14748622;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HPCT-05-wt
AC CVCL_9W33
SY Human Proximal Convoluted Tubule-05-wt
DR ECACC; 12020703
RX PubMed=14748622;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 9
ST D16S539: 11,13
ST D5S818: 12,13
ST D7S820: 9,12
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HPCT-06-wt
AC CVCL_9W34
SY Human Proximal Convoluted Tubule-06-wt
RX PubMed=14748622;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HPCT-1E3
AC CVCL_DG56
SY HPCT 1E3; HPCT clone 1E3
RX PubMed=7813520;
RX PubMed=7813521;
RX PubMed=8738419;
RX PubMed=24329745;
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0269 ! Fao
CA Hybrid cell line
//
ID HPCT-1F9
AC CVCL_ER20
SY HPCT 1F9; HPCT clone 1F9
RX PubMed=7813520;
RX PubMed=7813521;
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0269 ! Fao
CA Hybrid cell line
//
ID HPCT-2E9
AC CVCL_ER21
SY HPCT 2E9; HPCT clone 2E9
RX PubMed=7813520;
RX PubMed=7813521;
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0269 ! Fao
CA Hybrid cell line
//
ID HPD-1NR
AC CVCL_2072
SY HPD1NR
DR CLO; CLO_0003818
DR DSMZ; ACC-314
DR TKG; TKG 0722
RX PubMed=7868943;
CC Doubling time: ~60-70 hours (DSMZ).
CC Transformant: ChEBI; CHEBI:131518; N,N-bis(2-hydroxypropyl)nitrosamine (Diisopropanolnitrosamine; DIPN; N-nitrosobis(2-hydroxypropyl)amine).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
OI CVCL_2073 ! HPD-2NR
OI CVCL_T289 ! HPD-3NR
SX Female
CA Cancer cell line
//
ID HPD-2NR
AC CVCL_2073
SY HPD2NR
DR CLO; CLO_0003819
DR DSMZ; ACC-293
DR TKG; TKG 0723
RX PubMed=7868943;
CC Doubling time: ~40 hours (DSMZ).
CC Transformant: ChEBI; CHEBI:131518; N,N-bis(2-hydroxypropyl)nitrosamine (Diisopropanolnitrosamine; DIPN; N-nitrosobis(2-hydroxypropyl)amine).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
OI CVCL_2072 ! HPD-1NR
OI CVCL_T289 ! HPD-3NR
SX Female
CA Cancer cell line
//
ID HPD-3NR
AC CVCL_T289
SY HPD3NR
DR TKG; TKG 0724
RX PubMed=7868943;
CC Transformant: ChEBI; CHEBI:131518; N,N-bis(2-hydroxypropyl)nitrosamine (Diisopropanolnitrosamine; DIPN; N-nitrosobis(2-hydroxypropyl)amine).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
OI CVCL_2072 ! HPD-1NR
OI CVCL_2073 ! HPD-2NR
SX Female
CA Cancer cell line
//
ID HPDE
AC CVCL_4376
SY Human Pancreatic Duct Epithelial
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=HPDE
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HPDE-1/E6E7
AC CVCL_S973
SY HPDE1/E6E7
RX PubMed=8669463;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HPDE-4/E6E7
AC CVCL_S974
SY HPDE4/E6E7; HPDE4
RX DOI=10.4172/jpb.1000057;
RX PubMed=8669463;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
CC Omics: Proteome analysis by 2D-DE/MS.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HPDE-5/E6E7
AC CVCL_S975
SY HPDE5/E6E7
RX PubMed=8669463;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HPDE-6/E6E7
AC CVCL_S972
SY HPDE6/E6E7; HPDE6-E6E7; HPDE6E6E7
DR EFO; EFO_0005711
DR ENCODE; ENCBS224AAA
DR GEO; GSM621854
DR GEO; GSM816639
RX PubMed=11073822;
WW http://genome.ucsc.edu/encode/protocols/cell/human/HPDE6-E6E7_Crawford_protocol.pdf
CC Part of: ENCODE project common cell types; tier 3.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID HPDE6c11
AC CVCL_0P37
RX PubMed=11073822;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S972 ! HPDE-6/E6E7
SX Female
CA Transformed cell line
//
ID HPDE6c7
AC CVCL_0P38
SY H6c7; H6C7
RX DOI=10.4172/jpb.1000057;
RX PubMed=11073822;
WW https://www.kerafast.com/product/2101/human-pancreatic-duct-epithelial-cell-line-h6c7
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
CC Omics: Proteome analysis by 2D-DE/MS.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S972 ! HPDE-6/E6E7
SX Female
CA Transformed cell line
//
ID hPES-1
AC CVCL_B529
SY HPES-1; GUCASe001-A
DR hPSCreg; GUCASe001-A
RX PubMed=18071366;
CC From: Graduate University of Chinese Academy of Sciences Institute of Zoology; Beijing; China.
ST Source(s): PubMed=18071366
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 10
ST D18S51: 14,15
ST D21S11: 30,31
ST D3S1358: 16
ST D5S818: 9,11
ST D7S820: 9,12
ST D8S1179: 15
ST FGA: 14,15
ST Penta D: 11
ST Penta E: 15,20
ST TH01: 9
ST TPOX: 9,11
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID hPES-2
AC CVCL_B530
SY HPES-2; GUCASe002-A
DR hPSCreg; GUCASe002-A
RX PubMed=18071366;
CC From: Graduate University of Chinese Academy of Sciences Institute of Zoology; Beijing; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID HPET-1
AC CVCL_EQ24
SY HPET1; Human Prostate Epithelial/hTERT-1
RX PubMed=17510410;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EQ25 ! HPET-5
OI CVCL_EQ26 ! HPET-11
OI CVCL_EQ27 ! HPET-13
SX Male
CA Telomerase immortalized cell line
//
ID HPET-11
AC CVCL_EQ26
SY HPET11; Human Prostate Epithelial/hTERT-11
DR GEO; GSM844559
RX PubMed=17510410;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transfected with: HGNC; 11730; TERT.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EQ24 ! HPET-1
OI CVCL_EQ25 ! HPET-5
OI CVCL_EQ27 ! HPET-13
SX Male
CA Telomerase immortalized cell line
//
ID HPET-13
AC CVCL_EQ27
SY HPET13; Human Prostate Epithelial/hTERT-13
DR GEO; GSM844560
DR GEO; GSM844561
RX PubMed=17510410;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transfected with: HGNC; 11730; TERT.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EQ24 ! HPET-1
OI CVCL_EQ25 ! HPET-5
OI CVCL_EQ26 ! HPET-11
SX Male
CA Telomerase immortalized cell line
//
ID HPET-5
AC CVCL_EQ25
SY HPET5; Human Prostate Epithelial/hTERT-5
DR GEO; GSM844562
RX PubMed=17510410;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transfected with: HGNC; 11730; TERT.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EQ24 ! HPET-1
OI CVCL_EQ26 ! HPET-11
OI CVCL_EQ27 ! HPET-13
SX Male
CA Telomerase immortalized cell line
//
ID HPK-1A
AC CVCL_D890
SY HPK1A; HPK IA; HPKIA
DR BTO; BTO:0005276
RX DOI=10.1007/978-1-4612-0411-4_3;
RX PubMed=1742725;
RX PubMed=2838778;
RX PubMed=2556855;
RX PubMed=21439369;
CC Characteristics: Contains 2 to 3 copies of the complete HPV16 genomes arranged in a head-to-tail fashion and integrated at a single chromosomal site.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID HPK-1A-ras
AC CVCL_D891
SY HPK-1A/ras; HPK1A-ras; KiMSV/HPK-1A; K-ras/HPK-1A
DR BTO; BTO:0005275
RX DOI=10.1007/978-1-4612-0411-4_3;
RX PubMed=1742725;
RX PubMed=2556855;
CC Characteristics: Contains several complete HPV16 genomes arranged in a head-to-tail fashion and integrated at a single chromosomal site.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D890 ! HPK-1A
SX Male
CA Transformed cell line
//
ID HPL1A
AC CVCL_9863
DR EFO; EFO_0006907
RX PubMed=9354455;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9864 ! HPL1B
OI CVCL_9865 ! HPL1C
OI CVCL_8880 ! HPL1D
OI CVCL_9866 ! HPL1E
SX Female
CA Transformed cell line
//
ID HPL1B
AC CVCL_9864
DR EFO; EFO_0002705
RX PubMed=9354455;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9863 ! HPL1A
OI CVCL_9865 ! HPL1C
OI CVCL_8880 ! HPL1D
OI CVCL_9866 ! HPL1E
SX Female
CA Transformed cell line
//
ID HPL1C
AC CVCL_9865
DR EFO; EFO_0006908
RX PubMed=9354455;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9863 ! HPL1A
OI CVCL_9864 ! HPL1B
OI CVCL_8880 ! HPL1D
OI CVCL_9866 ! HPL1E
SX Female
CA Transformed cell line
//
ID HPL1D
AC CVCL_8880
DR BTO; BTO:0003214
DR EFO; EFO_0006909
RX PubMed=9354455;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9863 ! HPL1A
OI CVCL_9864 ! HPL1B
OI CVCL_9865 ! HPL1C
OI CVCL_9866 ! HPL1E
SX Female
CA Transformed cell line
//
ID HPL1E
AC CVCL_9866
DR EFO; EFO_0006910
RX PubMed=9354455;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9863 ! HPL1A
OI CVCL_9864 ! HPL1B
OI CVCL_9865 ! HPL1C
OI CVCL_8880 ! HPL1D
SX Female
CA Transformed cell line
//
ID HPLA-A3
AC CVCL_6G77
RX PubMed=22687401;
CC Transfected with: HGNC; 7968; NR1I2.
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C3728; Hepatoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0027 ! Hep-G2
SX Male
CA Cancer cell line
//
ID HPME
AC CVCL_3717
DR CLO; CLO_0003820
DR ATCC; CRL-6589
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6589; true.
OX NCBI_TaxID=10090; ! Mus musculus
CA Undefined cell line type
//
ID HPMEC-ST1.6R
AC CVCL_8712
RX PubMed=11742042;
RX PubMed=12453433;
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID hPOB-tert
AC CVCL_HA41
RX PubMed=11864909;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID Hpr-4
AC CVCL_4706
DR CLO; CLO_0051572
DR RCB; RCB1728
RX PubMed=8205225;
CC Selected for resistance to: ChEBI; CHEBI:16240; Hydrogen peroxide.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_2234 ! V79
SX Male
CA Spontaneously immortalized cell line
//
ID HPR600
AC CVCL_9U05
SY HPR-600
RX PubMed=8895552;
RX PubMed=11414198;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID HPRS-1
AC CVCL_8447
SY HPRS line 1; MDCC-HP1; HP1
RX PubMed=69431;
RX PubMed=4547318;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID HPRS-2
AC CVCL_8448
SY HPRS line 2; MDCC-HP2; HP2
RX PubMed=69431;
RX PubMed=4547318;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID HPS0059
AC CVCL_6C74
DR RCB; HPS0059
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPS0060
AC CVCL_6C75
DR RCB; HPS0060
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPS0078
AC CVCL_T927
DR RCB; HPS0078
DR SKIP; SKIP000223
DI NCIt; C84595; Bernard-Soulier syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0G87 ! HPS0191
CA Induced pluripotent stem cell
//
ID HPS0097
AC CVCL_T964
DR RCB; HPS0097
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID HPS0128
AC CVCL_Y980
SY A000005#1
DR RCB; HPS0128
DR SKIP; SKIP000031
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T969 ! HPS0129
OI CVCL_Y518 ! HPS0130
CA Induced pluripotent stem cell
//
ID HPS0129
AC CVCL_T969
SY A000005#2
DR RCB; HPS0129
DR SKIP; SKIP000032
DR SKIP; SKIP000272
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y980 ! HPS0128
OI CVCL_Y518 ! HPS0130
CA Induced pluripotent stem cell
//
ID HPS0130
AC CVCL_Y518
SY A000005#7
DR RCB; HPS0130
DR SKIP; SKIP000033
DR SKIP; SKIP000379
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y980 ! HPS0128
OI CVCL_T969 ! HPS0129
CA Induced pluripotent stem cell
//
ID HPS0131
AC CVCL_Y952
SY A000006#4-2
DR RCB; HPS0131
DR SKIP; SKIP000037
DI NCIt; C118846; Miyoshi muscular dystrophy 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y953 ! HPS0132
OI CVCL_T973 ! HPS0133
CA Induced pluripotent stem cell
//
ID HPS0132
AC CVCL_Y953
SY A000006#4-3
DR RCB; HPS0132
DR SKIP; SKIP000038
DI NCIt; C118846; Miyoshi muscular dystrophy 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y952 ! HPS0131
OI CVCL_T973 ! HPS0133
CA Induced pluripotent stem cell
//
ID HPS0133
AC CVCL_T973
SY A000006#6-1
DR RCB; HPS0133
DR SKIP; SKIP000039
DR SKIP; SKIP000273
DI NCIt; C118846; Miyoshi muscular dystrophy 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y952 ! HPS0131
OI CVCL_Y953 ! HPS0132
CA Induced pluripotent stem cell
//
ID HPS0134
AC CVCL_T970
SY A000007#5
DR RCB; HPS0134
DR SKIP; SKIP000040
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y974 ! HPS0135
OI CVCL_Y975 ! HPS0136
CA Induced pluripotent stem cell
//
ID HPS0135
AC CVCL_Y974
SY A000007#6
DR RCB; HPS0135
DR SKIP; SKIP000041
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T970 ! HPS0134
OI CVCL_Y975 ! HPS0136
CA Induced pluripotent stem cell
//
ID HPS0136
AC CVCL_Y975
SY A000007#7
DR RCB; HPS0136
DR SKIP; SKIP000042
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T970 ! HPS0134
OI CVCL_Y974 ! HPS0135
CA Induced pluripotent stem cell
//
ID HPS0140
AC CVCL_T967
SY A000010#1-8
DR RCB; HPS0140
DR SKIP; SKIP000046
DR SKIP; SKIP000613
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y978 ! HPS0141
OI CVCL_Y979 ! HPS0142
CA Induced pluripotent stem cell
//
ID HPS0141
AC CVCL_Y978
SY A000010#3-3
DR RCB; HPS0141
DR SKIP; SKIP000047
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T967 ! HPS0140
OI CVCL_Y979 ! HPS0142
CA Induced pluripotent stem cell
//
ID HPS0142
AC CVCL_Y979
SY A000010#3-4
DR RCB; HPS0142
DR SKIP; SKIP000048
DR SKIP; SKIP000614
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T967 ! HPS0140
OI CVCL_Y978 ! HPS0141
CA Induced pluripotent stem cell
//
ID HPS0143
AC CVCL_T966
DR RCB; HPS0143
DR SKIP; SKIP000274
DI NCIt; C120046; Congenital fiber-type disproportion
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1Q64 ! HPS0145
CA Induced pluripotent stem cell
//
ID HPS0145
AC CVCL_1Q64
DR RCB; HPS0145
DR SKIP; SKIP000624
DI NCIt; C120046; Congenital fiber-type disproportion
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T966 ! HPS0143
CA Induced pluripotent stem cell
//
ID HPS0146
AC CVCL_T968
SY A000023#7
DR RCB; HPS0146
DR SKIP; SKIP000052
DR SKIP; SKIP000275
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y976 ! HPS0147
OI CVCL_Y977 ! HPS0148
CA Induced pluripotent stem cell
//
ID HPS0147
AC CVCL_Y976
SY A000023#10
DR RCB; HPS0147
DR SKIP; SKIP000053
DR SKIP; SKIP000615
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T968 ! HPS0146
OI CVCL_Y977 ! HPS0148
CA Induced pluripotent stem cell
//
ID HPS0148
AC CVCL_Y977
SY A000023#11
DR RCB; HPS0148
DR SKIP; SKIP000054
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T968 ! HPS0146
OI CVCL_Y976 ! HPS0147
CA Induced pluripotent stem cell
//
ID HPS0155
AC CVCL_Y691
SY A000088#8
DR RCB; HPS0155
DR SKIP; SKIP000061
DI NCIt; C118632; Bardet-Biedl syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T928 ! HPS0156
OI CVCL_Y519 ! HPS0157
CA Induced pluripotent stem cell
//
ID HPS0156
AC CVCL_T928
SY A000088#10
DR RCB; HPS0156
DR SKIP; SKIP000062
DR SKIP; SKIP000264
DI NCIt; C118632; Bardet-Biedl syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y691 ! HPS0155
OI CVCL_Y519 ! HPS0157
CA Induced pluripotent stem cell
//
ID HPS0157
AC CVCL_Y519
SY A000088#12
DR RCB; HPS0157
DR SKIP; SKIP000063
DR SKIP; SKIP000380
DI NCIt; C118632; Bardet-Biedl syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y691 ! HPS0155
OI CVCL_T928 ! HPS0156
CA Induced pluripotent stem cell
//
ID HPS0164
AC CVCL_T929
DR RCB; HPS0164
DR SKIP; SKIP000245
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID HPS0169
AC CVCL_T930
DR RCB; HPS0169
DR SKIP; SKIP000244
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1Q65 ! HPS0171
CA Induced pluripotent stem cell
//
ID HPS0171
AC CVCL_1Q65
DR RCB; HPS0171
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T930 ! HPS0169
CA Induced pluripotent stem cell
//
ID HPS0172
AC CVCL_Y919
SY A000009#2
DR RCB; HPS0172
DR SKIP; SKIP000064
DI NCIt; C26744; Dermatomyositis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y920 ! HPS0173
OI CVCL_T931 ! HPS0174
CA Induced pluripotent stem cell
//
ID HPS0173
AC CVCL_Y920
SY A000009#6
DR RCB; HPS0173
DR SKIP; SKIP000065
DI NCIt; C26744; Dermatomyositis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y919 ! HPS0172
OI CVCL_T931 ! HPS0174
CA Induced pluripotent stem cell
//
ID HPS0174
AC CVCL_T931
SY A000009#7
DR RCB; HPS0174
DR SKIP; SKIP000066
DR SKIP; SKIP000243
DI NCIt; C26744; Dermatomyositis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y919 ! HPS0172
OI CVCL_Y920 ! HPS0173
CA Induced pluripotent stem cell
//
ID HPS0175
AC CVCL_T932
SY A000027#32-1
DR RCB; HPS0175
DR SKIP; SKIP000079
DR SKIP; SKIP000249
DI NCIt; C84734; Glycogen storage disease type II
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T933 ! HPS0176
OI CVCL_T934 ! HPS0177
CA Induced pluripotent stem cell
//
ID HPS0176
AC CVCL_T933
SY A000027#33-1
DR RCB; HPS0176
DR SKIP; SKIP000080
DR SKIP; SKIP000250
DI NCIt; C84734; Glycogen storage disease type II
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T932 ! HPS0175
OI CVCL_T934 ! HPS0177
CA Induced pluripotent stem cell
//
ID HPS0177
AC CVCL_T934
SY A000027#34-2
DR RCB; HPS0177
DR SKIP; SKIP000081
DR SKIP; SKIP000251
DI NCIt; C84734; Glycogen storage disease type II
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T932 ! HPS0175
OI CVCL_T933 ! HPS0176
CA Induced pluripotent stem cell
//
ID HPS0178
AC CVCL_T935
DR RCB; HPS0178
DR SKIP; SKIP000242
DI NCIt; C72070; Systemic scleroderma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6C76 ! HPS0180
CA Induced pluripotent stem cell
//
ID HPS0180
AC CVCL_6C76
DR RCB; HPS0180
DI NCIt; C72070; Systemic scleroderma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T935 ! HPS0178
CA Induced pluripotent stem cell
//
ID HPS0181
AC CVCL_Y924
SY A000066#2
DR RCB; HPS0181
DR SKIP; SKIP000085
DI NCIt; C84786; Inclusion body myositis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y925 ! HPS0182
OI CVCL_T936 ! HPS0183
CA Induced pluripotent stem cell
//
ID HPS0182
AC CVCL_Y925
SY A000066#3
DR RCB; HPS0182
DR SKIP; SKIP000086
DI NCIt; C84786; Inclusion body myositis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y924 ! HPS0181
OI CVCL_T936 ! HPS0183
CA Induced pluripotent stem cell
//
ID HPS0183
AC CVCL_T936
SY A000066#5
DR RCB; HPS0183
DR SKIP; SKIP000087
DR SKIP; SKIP000241
DI NCIt; C84786; Inclusion body myositis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y924 ! HPS0181
OI CVCL_Y925 ! HPS0182
CA Induced pluripotent stem cell
//
ID HPS0184
AC CVCL_T937
DR RCB; HPS0184
DR SKIP; SKIP000240
DI NCIt; C72070; Systemic scleroderma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6C77 ! HPS0185
OI CVCL_IP64 ! HPS0186
CA Induced pluripotent stem cell
//
ID HPS0185
AC CVCL_6C77
DR RCB; HPS0185
DI NCIt; C72070; Systemic scleroderma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T937 ! HPS0184
OI CVCL_IP64 ! HPS0186
CA Induced pluripotent stem cell
//
ID HPS0186
AC CVCL_IP64
DR RCB; HPS0186
DI NCIt; C72070; Systemic scleroderma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T937 ! HPS0184
OI CVCL_6C77 ! HPS0185
CA Induced pluripotent stem cell
//
ID HPS0191
AC CVCL_0G87
DR RCB; HPS0191
DR SKIP; SKIP000555
DI NCIt; C84595; Bernard-Soulier syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T927 ! HPS0078
CA Induced pluripotent stem cell
//
ID HPS0192
AC CVCL_T971
DR RCB; HPS0192
DR SKIP; SKIP000279
DI NCIt; C79532; Allergic rhinitis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID HPS0207
AC CVCL_Y522
SY A000126#1
DR RCB; HPS0207
DR SKIP; SKIP000100
DR SKIP; SKIP000388
DI NCIt; C118631; Alpha thalassemia X-linked mental retardation syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y968 ! HPS0208
CA Induced pluripotent stem cell
//
ID HPS0208
AC CVCL_Y968
SY A000126#2
DR RCB; HPS0208
DR SKIP; SKIP000101
DI NCIt; C118631; Alpha thalassemia X-linked mental retardation syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y522 ! HPS0207
CA Induced pluripotent stem cell
//
ID HPS0209
AC CVCL_T974
SY A000145#3-1
DR RCB; HPS0209
DR SKIP; SKIP000102
DR SKIP; SKIP000280
DI NCIt; C3120; Pulmonary hypertension
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y933 ! HPS0210
OI CVCL_Y934 ! HPS0211
CA Induced pluripotent stem cell
//
ID HPS0210
AC CVCL_Y933
SY A000145#3-2
DR RCB; HPS0210
DR SKIP; SKIP000103
DI NCIt; C3120; Pulmonary hypertension
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T974 ! HPS0209
OI CVCL_Y934 ! HPS0211
CA Induced pluripotent stem cell
//
ID HPS0211
AC CVCL_Y934
SY A000145#3-4
DR RCB; HPS0211
DR SKIP; SKIP000104
DI NCIt; C3120; Pulmonary hypertension
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T974 ! HPS0209
OI CVCL_Y933 ! HPS0210
CA Induced pluripotent stem cell
//
ID HPS0214
AC CVCL_T938
DR RCB; HPS0214
DR SKIP; SKIP000239
DI NCIt; C34568; Ehlers-Danlos syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID HPS0215
AC CVCL_T972
DR RCB; HPS0215
DR SKIP; SKIP000281
DI NCIt; C84895; Moyamoya disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IP65 ! HPS0217
CA Induced pluripotent stem cell
//
ID HPS0217
AC CVCL_IP65
DR RCB; HPS0217
DI NCIt; C84895; Moyamoya disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T972 ! HPS0215
CA Induced pluripotent stem cell
//
ID HPS0224
AC CVCL_T939
SY A000002#2-1
DR RCB; HPS0224
DR SKIP; SKIP000111
DR SKIP; SKIP000238
DI NCIt; C84554; Familial amyloid neuropathy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y972 ! HPS0225
OI CVCL_Y973 ! HPS0226
CA Induced pluripotent stem cell
//
ID HPS0225
AC CVCL_Y972
SY A000002#2-2
DR RCB; HPS0225
DR SKIP; SKIP000112
DI NCIt; C84554; Familial amyloid neuropathy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T939 ! HPS0224
OI CVCL_Y973 ! HPS0226
CA Induced pluripotent stem cell
//
ID HPS0226
AC CVCL_Y973
SY A000002#2-5
DR RCB; HPS0226
DR SKIP; SKIP000113
DI NCIt; C84554; Familial amyloid neuropathy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T939 ! HPS0224
OI CVCL_Y972 ! HPS0225
CA Induced pluripotent stem cell
//
ID HPS0227
AC CVCL_Y516
SY A000003#3-6
DR RCB; HPS0227
DR SKIP; SKIP000114
DR SKIP; SKIP000389
DI NCIt; C84554; Familial amyloid neuropathy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y971 ! HPS0228
CA Induced pluripotent stem cell
//
ID HPS0228
AC CVCL_Y971
DR RCB; HPS0228
DR SKIP; SKIP000115
DI NCIt; C84554; Familial amyloid neuropathy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y516 ! HPS0227
CA Induced pluripotent stem cell
//
ID HPS0232
AC CVCL_Y929
SY A000018#18-12-2
DR RCB; HPS0232
DR SKIP; SKIP000119
DI NCIt; C84587; Becker's muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y520 ! HPS0233
OI CVCL_Y931 ! HPS0234
CA Induced pluripotent stem cell
//
ID HPS0233
AC CVCL_Y520
SY A000018#18-12-25
DR RCB; HPS0233
DR SKIP; SKIP000120
DR SKIP; SKIP000381
DI NCIt; C84587; Becker's muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y929 ! HPS0232
OI CVCL_Y931 ! HPS0234
CA Induced pluripotent stem cell
//
ID HPS0234
AC CVCL_Y931
SY A000018#18-15-8
DR RCB; HPS0234
DR SKIP; SKIP000121
DI NCIt; C84587; Becker's muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y929 ! HPS0232
OI CVCL_Y520 ! HPS0233
CA Induced pluripotent stem cell
//
ID HPS0244
AC CVCL_Y521
SY A000196#1
DR RCB; HPS0244
DR SKIP; SKIP000131
DR SKIP; SKIP000382
DI NCIt; C118631; Alpha thalassemia X-linked mental retardation syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y969 ! HPS0245
OI CVCL_Y970 ! HPS0246
CA Induced pluripotent stem cell
//
ID HPS0245
AC CVCL_Y969
SY A000196#5
DR RCB; HPS0245
DR SKIP; SKIP000132
DI NCIt; C118631; Alpha thalassemia X-linked mental retardation syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y521 ! HPS0244
OI CVCL_Y970 ! HPS0246
CA Induced pluripotent stem cell
//
ID HPS0246
AC CVCL_Y970
SY A000196#6
DR RCB; HPS0246
DR SKIP; SKIP000133
DI NCIt; C118631; Alpha thalassemia X-linked mental retardation syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y521 ! HPS0244
OI CVCL_Y969 ! HPS0245
CA Induced pluripotent stem cell
//
ID HPS0247
AC CVCL_6C78
DR RCB; HPS0247
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID HPS0248
AC CVCL_6C79
DR RCB; HPS0248
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID HPS0249
AC CVCL_6C80
DR RCB; HPS0249
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID HPS0254
AC CVCL_6C81
DR RCB; HPS0254
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID HPS0255
AC CVCL_6C82
DR RCB; HPS0255
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID HPS0256
AC CVCL_6C83
DR RCB; HPS0256
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID HPS0263
AC CVCL_6C84
DR RCB; HPS0263
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID HPS0264
AC CVCL_T944
DR RCB; HPS0264
DR SKIP; SKIP000265
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID HPS0265
AC CVCL_T940
DR RCB; HPS0265
DR SKIP; SKIP000237
DI NCIt; C3962; Adenosine deaminase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6C85 ! HPS0266
CA Induced pluripotent stem cell
//
ID HPS0266
AC CVCL_6C85
DR RCB; HPS0266
DI NCIt; C3962; Adenosine deaminase deficiency
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T940 ! HPS0265
CA Induced pluripotent stem cell
//
ID HPS0270
AC CVCL_T941
DR RCB; HPS0270
DR SKIP; SKIP000235
DI NCIt; C3001; Eczema
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T942 ! HPS0271
OI CVCL_T943 ! HPS0272
CA Induced pluripotent stem cell
//
ID HPS0271
AC CVCL_T942
DR RCB; HPS0271
DR SKIP; SKIP000236
DI NCIt; C3001; Eczema
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T941 ! HPS0270
OI CVCL_T943 ! HPS0272
CA Induced pluripotent stem cell
//
ID HPS0272
AC CVCL_T943
DR RCB; HPS0272
DR SKIP; SKIP000282
DI NCIt; C3001; Eczema
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T941 ! HPS0270
OI CVCL_T942 ! HPS0271
CA Induced pluripotent stem cell
//
ID HPS0312
AC CVCL_6C86
DR RCB; HPS0312
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID HPS0317
AC CVCL_1Q66
DR RCB; HPS0317
DR SKIP; SKIP000618
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1Q67 ! HPS0322
SX Female
CA Induced pluripotent stem cell
//
ID HPS0322
AC CVCL_1Q67
DR RCB; HPS0322
DR SKIP; SKIP000619
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1Q66 ! HPS0317
SX Female
CA Induced pluripotent stem cell
//
ID HPS0332
AC CVCL_1R58
DR RCB; HPS0332
DR SKIP; SKIP000627
DI NCIt; C26798; Hypophosphatasia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1R59 ! HPS0333
CA Induced pluripotent stem cell
//
ID HPS0333
AC CVCL_1R59
DR RCB; HPS0333
DR SKIP; SKIP000628
DI NCIt; C26798; Hypophosphatasia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1R58 ! HPS0332
CA Induced pluripotent stem cell
//
ID HPS0334
AC CVCL_1R65
DR RCB; HPS0334
DR SKIP; SKIP000629
DI NCIt; C26788; Chronic granulomatous disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1R66 ! HPS0335
OI CVCL_1R67 ! HPS0336
CA Induced pluripotent stem cell
//
ID HPS0335
AC CVCL_1R66
DR RCB; HPS0335
DR SKIP; SKIP000630
DI NCIt; C26788; Chronic granulomatous disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1R65 ! HPS0334
OI CVCL_1R67 ! HPS0336
CA Induced pluripotent stem cell
//
ID HPS0336
AC CVCL_1R67
DR RCB; HPS0336
DR SKIP; SKIP000631
DI NCIt; C26788; Chronic granulomatous disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1R65 ! HPS0334
OI CVCL_1R66 ! HPS0335
CA Induced pluripotent stem cell
//
ID HPS0337
AC CVCL_1T00
DR RCB; HPS0337
DR SKIP; SKIP000632
DI NCIt; C26788; Chronic granulomatous disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1T01 ! HPS0338
OI CVCL_1T02 ! HPS0339
CA Induced pluripotent stem cell
//
ID HPS0338
AC CVCL_1T01
DR RCB; HPS0338
DR SKIP; SKIP000633
DI NCIt; C26788; Chronic granulomatous disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1T00 ! HPS0337
OI CVCL_1T02 ! HPS0339
CA Induced pluripotent stem cell
//
ID HPS0339
AC CVCL_1T02
DR RCB; HPS0339
DR SKIP; SKIP000634
DI NCIt; C26788; Chronic granulomatous disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1T00 ! HPS0337
OI CVCL_1T01 ! HPS0338
CA Induced pluripotent stem cell
//
ID HPS0414
AC CVCL_IP66
DR RCB; HPS0414
DI NCIt; C129933; Primary lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID hPSC-1
AC CVCL_T767
DR RCB; RCB3586
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID hPSC-14
AC CVCL_T768
DR RCB; RCB3589
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID hPSC-5
AC CVCL_T769
DR RCB; RCB3588
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID HPSI0114i-bezi_1
AC CVCL_AE24
SY WTSIi041-A
DR BioSamples; SAMEA2518325
DR EBiSC; WTSIi041-A
DR ECACC; 66540037
DR ECACC; 77650042
DR HipSci; HPSI0114i-bezi_1
DR hPSCreg; WTSIi041-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE25 ! HPSI0114i-bezi_3
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0114i-bezi_3
AC CVCL_AE25
DR ECACC; 77650041
DR HipSci; HPSI0114i-bezi_3
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE24 ! HPSI0114i-bezi_1
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0114i-eipl_1
AC CVCL_AE06
SY WTSIi020-A
DR BioSamples; SAMEA2536417
DR EBiSC; WTSIi020-A
DR ECACC; 66540090
DR ECACC; 77650081
DR HipSci; HPSI0114i-eipl_1
DR hPSCreg; WTSIi020-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE21 ! HPSI0114i-eipl_3
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0114i-eipl_3
AC CVCL_AE21
SY WTSIi020-B
DR BioSamples; SAMEA2536405
DR EBiSC; WTSIi020-B
DR ECACC; 66540239
DR ECACC; 77650198
DR HipSci; HPSI0114i-eipl_3
DR hPSCreg; WTSIi020-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE06 ! HPSI0114i-eipl_1
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0114i-fikt_2
AC CVCL_AE26
DR HipSci; HPSI0114i-fikt_2
CC From: Cambridge BioResource; Cambridge; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE27 ! HPSI0114i-fikt_3
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0114i-fikt_3
AC CVCL_AE27
SY WTSIi072-A
DR BioSamples; SAMEA2547619
DR EBiSC; WTSIi072-A
DR ECACC; 66540184
DR ECACC; 77650106
DR HipSci; HPSI0114i-fikt_3
DR hPSCreg; WTSIi072-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE26 ! HPSI0114i-fikt_2
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0114i-iisa_1
AC CVCL_AE22
SY WTSIi019-B
DR BioSamples; SAMEA2536412
DR EBiSC; WTSIi019-B
DR ECACC; 66540129
DR ECACC; 77650096
DR HipSci; HPSI0114i-iisa_1
DR hPSCreg; WTSIi019-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE05 ! HPSI0114i-iisa_3
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0114i-iisa_3
AC CVCL_AE05
SY WTSIi019-A
DR BioSamples; SAMEA2536410
DR EBiSC; WTSIi019-A
DR ECACC; 66540089
DR ECACC; 77650082
DR HipSci; HPSI0114i-iisa_3
DR hPSCreg; WTSIi019-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE22 ! HPSI0114i-iisa_1
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0114i-joxm_1
AC CVCL_AE28
SY WTSIi074-A
DR BioSamples; SAMEA2547637
DR EBiSC; WTSIi074-A
DR ECACC; 66540186
DR ECACC; 77650047
DR HipSci; HPSI0114i-joxm_1
DR hPSCreg; WTSIi074-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0114i-kolf_2
AC CVCL_AE29
SY WTSIi018-B
DR BioSamples; SAMEA2547615
DR ECACC; 77650100
DR HipSci; HPSI0114i-kolf_2
DR hPSCreg; WTSIi018-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE30 ! HPSI0114i-kolf_3
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0114i-Kolf_2-C1
AC CVCL_9S58
SY WTSIi018-B-1
DR hPSCreg; WTSIi018-B-1
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AE29 ! HPSI0114i-kolf_2
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0114i-kolf_3
AC CVCL_AE30
SY WTSIi018-A
DR BioSamples; SAMEA2547644
DR EBiSC; WTSIi018-A
DR ECACC; 66540088
DR ECACC; 77650048
DR HipSci; HPSI0114i-kolf_3
DR hPSCreg; WTSIi018-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE29 ! HPSI0114i-kolf_2
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0114i-lexy_1
AC CVCL_AE31
SY WTSIi017-B
DR BioSamples; SAMEA2536416
DR EBiSC; WTSIi017-B
DR ECACC; 66540187
DR ECACC; 77650054
DR HipSci; HPSI0114i-lexy_1
DR hPSCreg; WTSIi017-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE32 ! HPSI0114i-lexy_2
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0114i-lexy_2
AC CVCL_AE32
SY WTSIi017-A
DR BioSamples; SAMEA2536404
DR EBiSC; WTSIi017-A
DR ECACC; 66540087
DR HipSci; HPSI0114i-lexy_2
DR hPSCreg; WTSIi017-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE31 ! HPSI0114i-lexy_1
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0114i-oevr_3
AC CVCL_AE04
SY WTSIi016-A
DR BioSamples; SAMEA2570435
DR EBiSC; WTSIi016-A
DR ECACC; 66540086
DR ECACC; 77650072
DR HipSci; HPSI0114i-oevr_3
DR hPSCreg; WTSIi016-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0114i-rozh_4
AC CVCL_AE33
SY WTSIi015-B
DR BioSamples; SAMEA2555017
DR EBiSC; WTSIi015-B
DR ECACC; 66540113
DR ECACC; 77650050
DR HipSci; HPSI0114i-rozh_4
DR hPSCreg; WTSIi015-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE34 ! HPSI0114i-rozh_5
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0114i-rozh_5
AC CVCL_AE34
SY WTSIi015-A
DR BioSamples; SAMEA2555012
DR EBiSC; WTSIi015-A
DR ECACC; 66540085
DR ECACC; 77650043
DR HipSci; HPSI0114i-rozh_5
DR hPSCreg; WTSIi015-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE33 ! HPSI0114i-rozh_4
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0114i-vabj_3
AC CVCL_AE35
SY WTSIi024-A
DR BioSamples; SAMEA2595426
DR EBiSC; WTSIi024-A
DR ECACC; 66540094
DR ECACC; 77650053
DR HipSci; HPSI0114i-vabj_3
DR hPSCreg; WTSIi024-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0114i-vass_1
AC CVCL_AE36
SY WTSIi075-A
DR BioSamples; SAMEA2627141
DR EBiSC; WTSIi075-A
DR ECACC; 66540188
DR ECACC; 77650044
DR HipSci; HPSI0114i-vass_1
DR hPSCreg; WTSIi075-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0114i-veui_3
AC CVCL_AE37
SY WTSIi148-A
DR BioSamples; SAMEA2464772
DR ECACC; 77650267
DR HipSci; HPSI0114i-veui_3
DR hPSCreg; WTSIi143-A
CC From: University College London; London; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
DI NCIt; C118632; Bardet-Biedl syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0114i-wegi_1
AC CVCL_AE38
SY WTSIi144-A
DR BioSamples; SAMEA2547631
DR EBiSC; WTSIi144-A
DR ECACC; 66540254
DR ECACC; 77650197
DR HipSci; HPSI0114i-wegi_1
DR hPSCreg; WTSIi144-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0114i-zapk_2
AC CVCL_AE39
SY WTSIi023-B
DR BioSamples; SAMEA2570426
DR EBiSC; WTSIi023-B
DR ECACC; 66540261
DR ECACC; 77650195
DR HipSci; HPSI0114i-zapk_2
DR hPSCreg; WTSIi023-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE40 ! HPSI0114i-zapk_3
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0114i-zapk_3
AC CVCL_AE40
SY WTSIi023-A
DR BioSamples; SAMEA2570432
DR EBiSC; WTSIi023-A
DR ECACC; 66540093
DR ECACC; 77650156
DR HipSci; HPSI0114i-zapk_3
DR hPSCreg; WTSIi023-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE39 ! HPSI0114i-zapk_2
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0114i-zoxy_3
AC CVCL_AE41
SY WTSIi037-A
DR BioSamples; SAMEA2536413
DR ECACC; 77650164
DR HipSci; HPSI0114i-zoxy_3
DR hPSCreg; WTSIi037-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0115i-aion_2
AC CVCL_EE75
DR HipSci; HPSI0115i-aion_2
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE76 ! HPSI0115i-aion_3
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0115i-aion_3
AC CVCL_EE76
DR HipSci; HPSI0115i-aion_3
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE75 ! HPSI0115i-aion_2
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0115i-gifk_1
AC CVCL_AJ81
DR HipSci; HPSI0115i-gifk_1
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0115i-hecn_3
AC CVCL_EE77
DR HipSci; HPSI0115i-hecn_3
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE78 ! HPSI0115i-hecn_6
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0115i-hecn_6
AC CVCL_EE78
DR HipSci; HPSI0115i-hecn_6
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE77 ! HPSI0115i-hecn_3
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0115i-iiyk_2
AC CVCL_EE79
DR HipSci; HPSI0115i-iiyk_2
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE80 ! HPSI0115i-iiyk_4
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0115i-iiyk_4
AC CVCL_EE80
DR HipSci; HPSI0115i-iiyk_4
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE79 ! HPSI0115i-iiyk_2
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0115i-melw_1
AC CVCL_AJ82
DR HipSci; HPSI0115i-melw_1
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AJ83 ! HPSI0115i-melw_2
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0115i-melw_2
AC CVCL_AJ83
DR HipSci; HPSI0115i-melw_2
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AJ82 ! HPSI0115i-melw_1
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0115i-qoog_4
AC CVCL_EE81
DR HipSci; HPSI0115i-qoog_4
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE82 ! HPSI0115i-qoog_6
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0115i-qoog_6
AC CVCL_EE82
DR HipSci; HPSI0115i-qoog_6
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE81 ! HPSI0115i-qoog_4
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0115i-uolo_5
AC CVCL_AE42
DR HipSci; HPSI0115i-uolo_5
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0115i-vazt_1
AC CVCL_EE83
DR HipSci; HPSI0115i-vazt_1
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE84 ! HPSI0115i-vazt_2
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0115i-vazt_2
AC CVCL_EE84
DR HipSci; HPSI0115i-vazt_2
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE83 ! HPSI0115i-vazt_1
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0115i-zihe_1
AC CVCL_AJ84
DR HipSci; HPSI0115i-zihe_1
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0213i-koun_2
AC CVCL_AE43
DR HipSci; HPSI0213i-koun_2
CC From: Cambridge BioResource; Cambridge; UK.
CC Omics: Cellular phenotyping.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE44 ! HPSI0213i-koun_4
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0213i-koun_4
AC CVCL_AE44
DR HipSci; HPSI0213i-koun_4
CC From: Cambridge BioResource; Cambridge; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE43 ! HPSI0213i-koun_2
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0213i-nawk_5
AC CVCL_AE45
DR HipSci; HPSI0213i-nawk_5
CC From: Cambridge BioResource; Cambridge; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE46 ! HPSI0213i-nawk_55
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0213i-nawk_55
AC CVCL_AE46
DR HipSci; HPSI0213i-nawk_55
CC From: Cambridge BioResource; Cambridge; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE45 ! HPSI0213i-nawk_5
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0213i-xeaw_1
AC CVCL_AE47
DR HipSci; HPSI0213i-xeaw_1
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0214i-bute_2
AC CVCL_AE48
DR HipSci; HPSI0214i-bute_2
CC From: Cambridge BioResource; Cambridge; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0214i-datg_2
AC CVCL_AE49
SY WTSIi048-A
DR BioSamples; SAMEA2632921
DR EBiSC; WTSIi048-A
DR ECACC; 66540127
DR ECACC; 77650205
DR HipSci; HPSI0214i-datg_2
DR hPSCreg; WTSIi048-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0214i-eiwy_1
AC CVCL_AE50
SY WTSIi044-A
DR BioSamples; SAMEA2645805
DR EBiSC; WTSIi044-A
DR ECACC; 66540118
DR ECACC; 77650165
DR HipSci; HPSI0214i-eiwy_1
DR hPSCreg; WTSIi044-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0214i-feec_2
AC CVCL_AE51
SY WTSIi135-A
DR BioSamples; SAMEA2612471
DR EBiSC; WTSIi135-A
DR ECACC; 66540240
DR ECACC; 77650191
DR HipSci; HPSI0214i-feec_2
DR hPSCreg; WTSIi135-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE52 ! HPSI0214i-feec_3
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0214i-feec_3
AC CVCL_AE52
DR HipSci; HPSI0214i-feec_3
CC From: Cambridge BioResource; Cambridge; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE51 ! HPSI0214i-feec_2
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0214i-fiau_1
AC CVCL_AE53
DR HipSci; HPSI0214i-fiau_1
CC From: Cambridge BioResource; Cambridge; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0214i-giju_2
AC CVCL_AE54
DR HipSci; HPSI0214i-giju_2
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE55 ! HPSI0214i-giju_3
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0214i-giju_3
AC CVCL_AE55
DR HipSci; HPSI0214i-giju_3
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE54 ! HPSI0214i-giju_2
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0214i-heja_1
AC CVCL_AE56
SY WTSIi014-B
DR BioSamples; SAMEA2627577
DR EBiSC; WTSIi014-B
DR ECACC; 66540112
DR ECACC; 77650124
DR HipSci; HPSI0214i-heja_1
DR hPSCreg; WTSIi014-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE57 ! HPSI0214i-heja_2
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0214i-heja_2
AC CVCL_AE57
SY WTSIi014-A
DR BioSamples; SAMEA2627578
DR EBiSC; WTSIi014-A
DR ECACC; 66540084
DR ECACC; 77650085
DR HipSci; HPSI0214i-heja_2
DR hPSCreg; WTSIi014-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE56 ! HPSI0214i-heja_1
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0214i-heth_1
AC CVCL_AE58
SY WTSIi045-A
DR BioSamples; SAMEA2658090
DR EBiSC; WTSIi045-A
DR ECACC; 66540119
DR ECACC; 77650139
DR HipSci; HPSI0214i-heth_1
DR hPSCreg; WTSIi045-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0214i-kehc_2
AC CVCL_AE59
SY WTSIi076-A
DR BioSamples; SAMEA2658107
DR EBiSC; WTSIi076-A
DR ECACC; 66540189
DR ECACC; 77650052
DR HipSci; HPSI0214i-kehc_2
DR hPSCreg; WTSIi076-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0214i-kucg_2
AC CVCL_AE60
SY WTSIi013-A
DR BioSamples; SAMEA2645814
DR EBiSC; WTSIi013-A
DR ECACC; 66540083
DR ECACC; 77650065
DR HipSci; HPSI0214i-kucg_2
DR hPSCreg; WTSIi013-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0214i-pelm_1
AC CVCL_AE61
SY WTSIi030-B
DR BioSamples; SAMEA2678742
DR EBiSC; WTSIi030-B
DR ECACC; 66540128
DR ECACC; 77650089
DR HipSci; HPSI0214i-pelm_1
DR hPSCreg; WTSIi030-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE62 ! HPSI0214i-pelm_3
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0214i-pelm_3
AC CVCL_AE62
SY WTSIi030-A
DR BioSamples; SAMEA2678738
DR EBiSC; WTSIi030-A
DR ECACC; 66540100
DR ECACC; 77650070
DR HipSci; HPSI0214i-pelm_3
DR hPSCreg; WTSIi030-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE61 ! HPSI0214i-pelm_1
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0214i-poih_2
AC CVCL_EE42
SY WTSIi168-B
DR BioSamples; SAMEA3968761
DR ECACC; 77650304
DR HipSci; HPSI0214i-poih_2
DR hPSCreg; WTSIi168-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE43 ! HPSI0214i-poih_4
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0214i-poih_4
AC CVCL_EE43
SY WTSIi168-A
DR BioSamples; SAMEA3969686
DR EBiSC; WTSIi168-A
DR ECACC; 66540336
DR ECACC; 77650305
DR HipSci; HPSI0214i-poih_4
DR hPSCreg; WTSIi168-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE42 ! HPSI0214i-poih_2
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0214i-rayr_1
AC CVCL_AE63
SY WTSIi143-A
DR BioSamples; SAMEA2649534
DR EBiSC; WTSIi143-A
DR ECACC; 66540252
DR ECACC; 77650196
DR HipSci; HPSI0214i-rayr_1
DR hPSCreg; WTSIi143-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0214i-wibj_1
AC CVCL_AE64
SY WTSIi046-B
DR BioSamples; SAMEA2627566
DR EBiSC; WTSIi046-B
DR ECACC; 66540255
DR ECACC; 77650257
DR HipSci; HPSI0214i-wibj_1
DR hPSCreg; WTSIi046-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE65 ! HPSI0214i-wibj_2
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0214i-wibj_2
AC CVCL_AE65
SY WTSIi046-A
DR BioSamples; SAMEA2627567
DR EBiSC; WTSIi046-A
DR ECACC; 66540120
DR ECACC; 77650057
DR HipSci; HPSI0214i-wibj_2
DR hPSCreg; WTSIi046-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE64 ! HPSI0214i-wibj_1
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0215i-deyz_2
AC CVCL_AJ85
DR HipSci; HPSI0215i-deyz_2
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AJ86 ! HPSI0215i-deyz_3
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0215i-deyz_3
AC CVCL_AJ86
DR HipSci; HPSI0215i-deyz_3
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AJ85 ! HPSI0215i-deyz_2
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0215i-fawm_2
AC CVCL_EE55
SY WTSIi178-A
DR BioSamples; SAMEA3735541
DR EBiSC; WTSIi178-A
DR ECACC; 66540350
DR ECACC; 77650288
DR HipSci; HPSI0215i-fawm_2
DR hPSCreg; WTSIi178-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE56 ! HPSI0215i-fawm_4
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0215i-fawm_4
AC CVCL_EE56
SY WTSIi178-B
DR BioSamples; SAMEA3754916
DR EBiSC; WTSIi178-B
DR ECACC; 66540351
DR HipSci; HPSI0215i-fawm_4
DR hPSCreg; WTSIi178-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE55 ! HPSI0215i-fawm_2
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0215i-hipn_1
AC CVCL_AE66
DR HipSci; HPSI0215i-hipn_1
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE67 ! HPSI0215i-hipn_2
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0215i-hipn_2
AC CVCL_AE67
DR HipSci; HPSI0215i-hipn_2
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE66 ! HPSI0215i-hipn_1
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0215i-oilg_1
AC CVCL_AX08
DR ECACC; 77650300
DR HipSci; HPSI0215i-oilg_1
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_EE41 ! HPSI0215i-oilg_3
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0215i-oilg_3
AC CVCL_EE41
SY WTSIi191-A
DR BioSamples; SAMEA3485962
DR EBiSC; WTSIi191-A
DR ECACC; 66540417
DR ECACC; 77650301
DR HipSci; HPSI0215i-oilg_3
DR hPSCreg; WTSIi191-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AX08 ! HPSI0215i-oilg_1
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0215i-yoch_6
AC CVCL_EE85
DR HipSci; HPSI0215i-yoch_6
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0313i-airc_2
AC CVCL_AE68
SY WTSIi105-A
DR BioSamples; SAMEA2398371
DR HipSci; HPSI0313i-airc_2
DR hPSCreg; WTSIi105-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Cellular phenotyping.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE69 ! HPSI0313i-airc_6
OI CVCL_AE70 ! HPSI0313i-airc_66
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0313i-airc_6
AC CVCL_AE69
DR HipSci; HPSI0313i-airc_6
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE68 ! HPSI0313i-airc_2
OI CVCL_AE70 ! HPSI0313i-airc_66
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0313i-airc_66
AC CVCL_AE70
SY WTSIi105-B
DR BioSamples; SAMEA2399089
DR HipSci; HPSI0313i-airc_66
DR hPSCreg; WTSIi105-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Cellular phenotyping.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE68 ! HPSI0313i-airc_2
OI CVCL_AE69 ! HPSI0313i-airc_6
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0313i-cesj_1
AC CVCL_AE71
SY WTSIi108-A
DR BioSamples; SAMEA2398465
DR HipSci; HPSI0313i-cesj_1
DR hPSCreg; WTSIi108-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0313i-fecs_1
AC CVCL_AE72
DR HipSci; HPSI0313i-fecs_1
CC From: Cambridge BioResource; Cambridge; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE73 ! HPSI0313i-fecs_3
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0313i-fecs_3
AC CVCL_AE73
DR HipSci; HPSI0313i-fecs_3
CC From: Cambridge BioResource; Cambridge; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE72 ! HPSI0313i-fecs_1
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0313i-xovo_1
AC CVCL_AE74
DR HipSci; HPSI0313i-xovo_1
CC From: Cambridge BioResource; Cambridge; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE75 ! HPSI0313i-xovo_2
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0313i-xovo_2
AC CVCL_AE75
DR HipSci; HPSI0313i-xovo_2
CC From: Cambridge BioResource; Cambridge; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE74 ! HPSI0313i-xovo_1
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0314i-bipt_1
AC CVCL_AE76
SY WTSIi031-A
DR BioSamples; SAMEA2719619
DR EBiSC; WTSIi031-A
DR ECACC; 66540101
DR HipSci; HPSI0314i-bipt_1
DR hPSCreg; WTSIi031-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0314i-bubh_1
AC CVCL_AE77
SY WTSIi012-A
DR BioSamples; SAMEA2675459
DR EBiSC; WTSIi012-A
DR ECACC; 66540082
DR ECACC; 77650062
DR HipSci; HPSI0314i-bubh_1
DR hPSCreg; WTSIi012-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE78 ! HPSI0314i-bubh_3
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0314i-bubh_3
AC CVCL_AE78
SY WTSIi012-B
DR BioSamples; SAMEA2698309
DR EBiSC; WTSIi012-B
DR ECACC; 66540181
DR ECACC; 77650077
DR HipSci; HPSI0314i-bubh_3
DR hPSCreg; WTSIi012-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE77 ! HPSI0314i-bubh_1
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0314i-cuhk_1
AC CVCL_AE79
SY WTSIi077-A
DR BioSamples; SAMEA2682671
DR EBiSC; WTSIi077-A
DR ECACC; 66540190
DR ECACC; 77650049
DR HipSci; HPSI0314i-cuhk_1
DR hPSCreg; WTSIi077-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE80 ! HPSI0314i-cuhk_2
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0314i-cuhk_2
AC CVCL_AE80
DR HipSci; HPSI0314i-cuhk_2
CC From: Cambridge BioResource; Cambridge; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE79 ! HPSI0314i-cuhk_1
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0314i-fafq_1
AC CVCL_AE81
SY WTSIi078-A
DR BioSamples; SAMEA2711371
DR EBiSC; WTSIi078-A
DR ECACC; 66540191
DR ECACC; 77650090
DR HipSci; HPSI0314i-fafq_1
DR hPSCreg; WTSIi078-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0314i-hoik_1
AC CVCL_AE82
SY WTSIi026-A
DR BioSamples; SAMEA2698315
DR EBiSC; WTSIi026-A
DR ECACC; 66540096
DR ECACC; 77650129
DR HipSci; HPSI0314i-hoik_1
DR hPSCreg; WTSIi026-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0314i-qaqx_1
AC CVCL_AE83
SY WTSIi040-A
DR BioSamples; SAMEA2658084
DR EBiSC; WTSIi040-A
DR ECACC; 66540036
DR ECACC; 77650146
DR HipSci; HPSI0314i-qaqx_1
DR hPSCreg; WTSIi040-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0314i-qonc_1
AC CVCL_AE84
SY WTSIi011-B
DR BioSamples; SAMEA2707499
DR EBiSC; WTSIi011-B
DR ECACC; 66540192
DR ECACC; 77650084
DR HipSci; HPSI0314i-qonc_1
DR hPSCreg; WTSIi011-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE85 ! HPSI0314i-qonc_2
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0314i-qonc_2
AC CVCL_AE85
SY WTSIi011-A
DR BioSamples; SAMEA2707507
DR EBiSC; WTSIi011-A
DR ECACC; 66540081
DR ECACC; 77650074
DR HipSci; HPSI0314i-qonc_2
DR hPSCreg; WTSIi011-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE84 ! HPSI0314i-qonc_1
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0314i-sojd_2
AC CVCL_AE86
SY WTSIi073-B
DR BioSamples; SAMEA2627571
DR EBiSC; WTSIi073-B
DR ECACC; 66540253
DR ECACC; 77650184
DR HipSci; HPSI0314i-sojd_2
DR hPSCreg; WTSIi073-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE87 ! HPSI0314i-sojd_3
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0314i-sojd_3
AC CVCL_AE87
SY WTSIi073-A
DR ECACC; 66540185
DR ECACC; 77650126
DR HipSci; HPSI0314i-sojd_3
DR hPSCreg; WTSIi073-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE86 ! HPSI0314i-sojd_2
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0314i-wigw_2
AC CVCL_EE57
SY WTSIi179-A
DR BioSamples; SAMEA3969710
DR EBiSC; WTSIi179-A
DR ECACC; 66540352
DR ECACC; 77650315
DR HipSci; HPSI0314i-wigw_2
DR hPSCreg; WTSIi179-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0314i-xugn_1
AC CVCL_AE88
SY WTSIi010-A
DR BioSamples; SAMEA2645811
DR EBiSC; WTSIi010-A
DR ECACC; 66540080
DR ECACC; 77650055
DR HipSci; HPSI0314i-xugn_1
DR hPSCreg; WTSIi010-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE89 ! HPSI0314i-xugn_2
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0314i-xugn_2
AC CVCL_AE89
SY WTSIi010-B
DR BioSamples; SAMEA2645809
DR EBiSC; WTSIi010-B
DR ECACC; 66540111
DR ECACC; 77650144
DR HipSci; HPSI0314i-xugn_2
DR hPSCreg; WTSIi010-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE88 ! HPSI0314i-xugn_1
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0413i-bupo_4
AC CVCL_AE90
DR HipSci; HPSI0413i-bupo_4
CC From: Cambridge BioResource; Cambridge; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0413i-corn_1
AC CVCL_AE91
SY WTSIi053-A
DR BioSamples; SAMEA2677117
DR EBiSC; WTSIi053-A
DR ECACC; 66540150
DR ECACC; 77650219
DR HipSci; HPSI0413i-corn_1
DR hPSCreg; WTSIi053-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0413i-coxy_3
AC CVCL_AE92
SY WTSIi109-A
DR BioSamples; SAMEA2399264
DR HipSci; HPSI0413i-coxy_3
DR hPSCreg; WTSIi109-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Cellular phenotyping.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE93 ! HPSI0413i-coxy_33
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0413i-coxy_33
AC CVCL_AE93
SY WTSIi109-B
DR BioSamples; SAMEA2398219
DR EBiSC; WTSIi109-B
DR ECACC; 66540234
DR HipSci; HPSI0413i-coxy_33
DR hPSCreg; WTSIi109-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE92 ! HPSI0413i-coxy_3
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0413i-gomv_3
AC CVCL_AE94
DR HipSci; HPSI0413i-gomv_3
CC From: Cambridge BioResource; Cambridge; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0413i-iakz_1
AC CVCL_AE95
SY WTSIi102-B
DR BioSamples; SAMEA2398858
DR HipSci; HPSI0413i-iakz_1
DR hPSCreg; WTSIi102-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Cellular phenotyping.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE96 ! HPSI0413i-iakz_2
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0413i-iakz_2
AC CVCL_AE96
SY WTSIi102-A
DR BioSamples; SAMEA2397889
DR ECACC; 77650231
DR HipSci; HPSI0413i-iakz_2
DR hPSCreg; WTSIi102-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Cellular phenotyping.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE95 ! HPSI0413i-iakz_1
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0413i-nudd_1
AC CVCL_AE97
SY WTSIi054-A
DR BioSamples; SAMEA2399199
DR EBiSC; WTSIi054-A
DR ECACC; 66540149
DR ECACC; 77650188
DR HipSci; HPSI0413i-nudd_1
DR hPSCreg; WTSIi054-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE98 ! HPSI0413i-nudd_6
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0413i-nudd_6
AC CVCL_AE98
SY WTSIi054-B
DR BioSamples; SAMEA2398822
DR HipSci; HPSI0413i-nudd_6
DR hPSCreg; WTSIi054-B
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE97 ! HPSI0413i-nudd_1
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0413i-ougl_1
AC CVCL_AE99
SY WTSIi121-A
DR BioSamples; SAMEA2398316
DR ECACC; 77650110
DR HipSci; HPSI0413i-ougl_1
DR hPSCreg; WTSIi121-A
DR PRIDE; PXD003903
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Cellular phenotyping.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AF00 ! HPSI0413i-ougl_3
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0413i-ougl_3
AC CVCL_AF00
SY WTSIi121-B
DR BioSamples; SAMEA2398428
DR ECACC; 77650117
DR HipSci; HPSI0413i-ougl_3
DR hPSCreg; WTSIi121-B
DR PRIDE; PXD003903
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Cellular phenotyping.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AE99 ! HPSI0413i-ougl_1
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0413i-peop_2
AC CVCL_AF01
SY WTSIi122-A
DR BioSamples; SAMEA2399200
DR HipSci; HPSI0413i-peop_2
DR hPSCreg; WTSIi122-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AF02 ! HPSI0413i-peop_4
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0413i-peop_4
AC CVCL_AF02
DR HipSci; HPSI0413i-peop_4
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AF01 ! HPSI0413i-peop_2
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0413i-sukz_1
AC CVCL_AF03
SY WTSIi093-A
DR BioSamples; SAMEA2398007
DR EBiSC; WTSIi093-A
DR ECACC; 66540208
DR ECACC; 77650118
DR HipSci; HPSI0413i-sukz_1
DR hPSCreg; WTSIi093-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0413i-uahf_3
AC CVCL_AF04
SY WTSIi125-A
DR BioSamples; SAMEA2397812
DR HipSci; HPSI0413i-uahf_3
DR hPSCreg; WTSIi125-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Cellular phenotyping.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0413i-xekf_1
AC CVCL_AF05
SY WTSIi127-A
DR BioSamples; SAMEA2399123
DR HipSci; HPSI0413i-xekf_1
DR hPSCreg; WTSIi127-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Cellular phenotyping.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID HPSI0413i-xisg_2
AC CVCL_AF06
DR HipSci; HPSI0413i-xisg_2
CC From: Cambridge BioResource; Cambridge; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0413i-yotv_2
AC CVCL_AF07
DR ECACC; 77650153
DR HipSci; HPSI0413i-yotv_2
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AF08 ! HPSI0413i-yotv_3
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0413i-yotv_3
AC CVCL_AF08
DR HipSci; HPSI0413i-yotv_3
CC From: Cambridge BioResource; Cambridge; UK.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AF07 ! HPSI0413i-yotv_2
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0413i-yuze_1
AC CVCL_AF09
SY WTSIi128-A
DR BioSamples; SAMEA2397955
DR HipSci; HPSI0413i-yuze_1
DR hPSCreg; WTSIi128-A
CC From: Cambridge BioResource; Cambridge; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
CC Omics: Cellular phenotyping.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0414i-biiw_1
AC CVCL_AF10
SY WTSIi192-A
DR BioSamples; SAMEA2733282
DR EBiSC; WTSIi192-A
DR ECACC; 66540426
DR ECACC; 77650333
DR HipSci; HPSI0414i-biiw_1
CC From: University of Exeter Medical School; Exeter; UK.
CC From: Wellcome Trust Sanger Institute; Hinxton; UK.
DI NCIt; C2985; Diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0414i-ceik_1
AC CVCL_AF11
DR HipSci; HPSI0414i-ceik_1
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AF12 ! HPSI0414i-ceik_2
SX Male
CA Induced pluripotent stem cell
//
ID HPSI0414i-ceik_2
AC CVCL_AF12
DR HipSci; HPSI0414i-ceik_2
CC From: Cambridge BioResource; Cambridge; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AF11 ! HPSI0414i-ceik_1
SX Male
CA Induced pluripotent stem cell
- 公告/新闻
